candidate_genes,disease,celltype,y,user_question,full_query
"['CYTIP', 'ADCY2', 'DNAH10OS', 'XKR4', 'NDUFA3']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFA3,"Among the genes CYTIP, ADCY2, DNAH10OS, XKR4, and NDUFA3, which one exhibits the most specific expression in pancreatic epsilon cells and thereby represents the best candidate for targeted intervention in type 1 diabetes mellitus?","Among the genes CYTIP, ADCY2, DNAH10OS, XKR4, and NDUFA3, which one exhibits the most specific expression in pancreatic epsilon cells and thereby represents the best candidate for targeted intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from the PINNACLE database. Determine which pancreatic epsilon cell-activated genes overlap with these targets. Next, compute the average embedding of the overlapping set and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['RASGRF2-AS1', 'RAB3IP', 'NDUFB2', 'LINC02024', 'POLR2G']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFB2,"Among the following genes—RASGRF2-AS1, RAB3IP, NDUFB2, LINC02024, and POLR2G—which exhibits the highest cell-type specificity for pancreatic epsilon cells in the context of type 1 diabetes mellitus?","Among the following genes—RASGRF2-AS1, RAB3IP, NDUFB2, LINC02024, and POLR2G—which exhibits the highest cell-type specificity for pancreatic epsilon cells in the context of type 1 diabetes mellitus? Identify verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which pancreatic epsilon cell-activated genes in PINNACLE overlap with these therapeutic targets, defining the cell-type–specific targets for type 1 diabetes. Calculate the average embedding for this overlapping set and compute the cosine similarity between this average reference and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PIP5KL1', 'ZCCHC24', 'AGAP4', 'RPS26', 'PANK3']",type 1 diabetes mellitus,pancreatic epsilon cell,RPS26,"Among the genes PIP5KL1, ZCCHC24, AGAP4, RPS26, and PANK3, which one exhibits the highest cell-type specificity in pancreatic ε-cells, thereby representing the most promising target for type 1 diabetes mellitus intervention?","Among the genes PIP5KL1, ZCCHC24, AGAP4, RPS26, and PANK3, which one exhibits the highest cell-type specificity in pancreatic ε-cells, thereby representing the most promising target for type 1 diabetes mellitus intervention? Determine the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, identify the subset of these targets that overlap with genes activated in pancreatic epsilon cells, as defined in PINNACLE. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference embedding and each individual target’s embedding. If one gene exhibits a substantially higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['INS', 'LAX1', 'GATAD2B', 'GABARAPL1', 'IPO7']",type 1 diabetes mellitus,pancreatic epsilon cell,INS,"Which gene among INS, LAX1, GATAD2B, GABARAPL1, and IPO7 exhibits the highest cell-type specificity in pancreatic epsilon cells for use as a target in type 1 diabetes mellitus?","Which gene among INS, LAX1, GATAD2B, GABARAPL1, and IPO7 exhibits the highest cell-type specificity in pancreatic epsilon cells for use as a target in type 1 diabetes mellitus? Identify all validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes activated in pancreatic epsilon cells, and compute the average embedding for this overlapping set. Then, calculate the cosine similarity between this average and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CSKMT', 'PAK5', 'MT-ND1', 'KCNS1', 'DNAJB13']",type 1 diabetes mellitus,pancreatic epsilon cell,MT-ND1,"Among the genes CSKMT, PAK5, MT-ND1, KCNS1, and DNAJB13, which one shows the highest cell-type specificity in pancreatic epsilon cells for targeting type 1 diabetes mellitus?","Among the genes CSKMT, PAK5, MT-ND1, KCNS1, and DNAJB13, which one shows the highest cell-type specificity in pancreatic epsilon cells for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which pancreatic epsilon cell–activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific targets. Calculate the average embedding of this set as a reference, then compute the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['C4orf36', 'NDUFA1', 'SPON2', 'PARM1', 'MINCR']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFA1,"Which gene among C4orf36, NDUFA1, SPON2, PARM1, and MINCR exhibits the highest specificity in pancreatic epsilon cells for potential targeting in type 1 diabetes mellitus?","Which gene among C4orf36, NDUFA1, SPON2, PARM1, and MINCR exhibits the highest specificity in pancreatic epsilon cells for potential targeting in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of the pancreatic epsilon cell–activated genes in PINNACLE overlap with these targets. Compute the average embedding of these overlapping genes and calculate the cosine similarity between each individual target’s embedding and this average. If one gene exhibits a substantially higher cosine similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['DNAJC27-AS1', 'NDUFS7', 'ALG6', 'ALDH1L1-AS1', 'TP53TG3D']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFS7,"Which candidate gene—DNAJC27-AS1, NDUFS7, ALG6, ALDH1L1-AS1, or TP53TG3D—exhibits the highest cell-type specificity in pancreatic epsilon cells relevant to type 1 diabetes mellitus?","Which candidate gene—DNAJC27-AS1, NDUFS7, ALG6, ALDH1L1-AS1, or TP53TG3D—exhibits the highest cell-type specificity in pancreatic epsilon cells relevant to type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific PINNACLE embeddings. Next, determine which of these targets overlap with pancreatic epsilon cell–activated genes in PINNACLE. Compute the average embedding of this overlapping set and calculate the cosine similarity between this reference and each target’s embedding. If one gene shows markedly higher similarity than the others, nominate it as the prime candidate, providing concise, evidence-based justification for its biological relevance."
"['AWAT2', 'PLXNC1', 'AKIP1', 'LTBP3', 'NDUFB1']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFB1,"Which gene among AWAT2, PLXNC1, AKIP1, LTBP3, and NDUFB1 exhibits the highest cell-type specificity in pancreatic epsilon cells and could serve as the optimal target for type 1 diabetes mellitus?","Which gene among AWAT2, PLXNC1, AKIP1, LTBP3, and NDUFB1 exhibits the highest cell-type specificity in pancreatic epsilon cells and could serve as the optimal target for type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which activated genes in pancreatic epsilon cells (as identified in PINNACLE) overlap with these targets, forming the cell-type–specific target set. Compute the average embedding of these genes as a reference vector, then calculate the cosine similarity between this reference and the embedding of each individual target gene. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['COMMD6', 'LINC01180', 'SCUBE1', 'APBB3', 'FOXP4-AS1']",type 1 diabetes mellitus,pancreatic epsilon cell,COMMD6,"Which gene among COMMD6, LINC01180, SCUBE1, APBB3, and FOXP4-AS1 exhibits the highest cell-type specificity in pancreatic epsilon cells for targeting type 1 diabetes mellitus?","Which gene among COMMD6, LINC01180, SCUBE1, APBB3, and FOXP4-AS1 exhibits the highest cell-type specificity in pancreatic epsilon cells for targeting type 1 diabetes mellitus? Determine the confirmed therapeutic targets for type 1 diabetes mellitus. From PINNACLE, obtain the cell-type–specific embeddings for these targets and identify which pancreatic epsilon cell-activated genes overlap with them. Compute the average embedding of this overlapping set and calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance to type 1 diabetes mellitus."
"['TMEM258', 'LINC02731', 'TMEM225B', 'MYO5C', 'CASC8']",type 1 diabetes mellitus,pancreatic epsilon cell,TMEM258,"Which gene among TMEM258, LINC02731, TMEM225B, MYO5C, and CASC8 exhibits the highest cell-type specificity in pancreatic epsilon cells for targeting type 1 diabetes mellitus?","Which gene among TMEM258, LINC02731, TMEM225B, MYO5C, and CASC8 exhibits the highest cell-type specificity in pancreatic epsilon cells for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the pancreatic epsilon cell-activated genes present in PINNACLE, yielding the cell-type–specific targets for type 1 diabetes. Compute the average embedding for this set and then calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['NDUFA11', 'NDFIP1', 'DPEP1', 'LAP3', 'TRMU']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFA11,"Which gene among NDUFA11, NDFIP1, DPEP1, LAP3, and TRMU exhibits the highest cell-type specificity in pancreatic epsilon cells for targeting type 1 diabetes mellitus?","Which gene among NDUFA11, NDFIP1, DPEP1, LAP3, and TRMU exhibits the highest cell-type specificity in pancreatic epsilon cells for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which pancreatic epsilon cell-activated genes in PINNACLE overlap with these targets. Calculate the average embedding of this overlapping set, then compute the cosine similarity between the average and each individual target embedding. If a single gene demonstrates markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SOX5', 'SLC26A2', 'IL11RA', 'CCDC62', 'NDUFA13']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFA13,"Which gene among SOX5, SLC26A2, IL11RA, CCDC62, and NDUFA13 demonstrates the highest cell-type specificity in pancreatic epsilon cells for targeting type 1 diabetes mellitus?","Which gene among SOX5, SLC26A2, IL11RA, CCDC62, and NDUFA13 demonstrates the highest cell-type specificity in pancreatic epsilon cells for targeting type 1 diabetes mellitus? Identify verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the genes activated in pancreatic epsilon cells according to PINNACLE. Compute the average embedding of the overlapping genes and calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['INS', 'KLHDC8A', 'SLC25A22', 'NLRP12', 'ZBTB43']",type 1 diabetes mellitus,pancreatic epsilon cell,INS,"Which gene among INS, KLHDC8A, SLC25A22, NLRP12, and ZBTB43 exhibits the most specific expression in pancreatic epsilon cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among INS, KLHDC8A, SLC25A22, NLRP12, and ZBTB43 exhibits the most specific expression in pancreatic epsilon cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the genes activated in pancreatic epsilon cells reported in PINNACLE. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this average and each individual target’s embedding. If one gene demonstrates a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in the context of type 1 diabetes."
"['EMC10', 'MT-ND1', 'BMI1', 'GOLGA6L9', 'SPATA5L1']",type 1 diabetes mellitus,pancreatic epsilon cell,MT-ND1,"Which gene among EMC10, MT-ND1, BMI1, GOLGA6L9, and SPATA5L1 exhibits the highest cell-type specificity in pancreatic epsilon cells for targeting type 1 diabetes mellitus?","Which gene among EMC10, MT-ND1, BMI1, GOLGA6L9, and SPATA5L1 exhibits the highest cell-type specificity in pancreatic epsilon cells for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type-specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the genes activated in pancreatic epsilon cells according to PINNACLE, thereby defining a set of cell-type–specific targets. Compute the average embedding of this overlapping set, then calculate the cosine similarity between this average and the embedding of each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['NDUFB2', 'MAP3K2-DT', 'NTRK2', 'PRSS21', 'LINC02322']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFB2,"Which gene among NDUFB2, MAP3K2-DT, NTRK2, PRSS21, and LINC02322 exhibits the highest specificity of expression in pancreatic epsilon cells, thereby representing the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among NDUFB2, MAP3K2-DT, NTRK2, PRSS21, and LINC02322 exhibits the highest specificity of expression in pancreatic epsilon cells, thereby representing the most promising candidate for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes activated in pancreatic epsilon cells in PINNACLE to define the cell-type–specific targets for type 1 diabetes mellitus. Calculate the average embedding from this overlapping set as a reference vector, and then compute the cosine similarity between this reference and each individual target’s embedding. If one gene shows a strikingly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ETV7-AS1', 'KIF20B', 'LINC00239', 'NDUFA11', 'ASPHD1']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFA11,"Among the genes ETV7-AS1, KIF20B, LINC00239, NDUFA11, and ASPHD1, which one demonstrates the highest specificity for pancreatic epsilon cells and represents the most promising target for type 1 diabetes mellitus interventions?","Among the genes ETV7-AS1, KIF20B, LINC00239, NDUFA11, and ASPHD1, which one demonstrates the highest specificity for pancreatic epsilon cells and represents the most promising target for type 1 diabetes mellitus interventions? Identify all validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from the PINNACLE database. Determine which pancreatic epsilon cell-activated genes overlap with these targets, and compute the average embedding for this overlapping set. Next, calculate the cosine similarity between this average embedding and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFA3', 'PCMTD1', 'RRS1', 'PCDH20', 'C6orf226']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFA3,"Which gene among NDUFA3, PCMTD1, RRS1, PCDH20, and C6orf226 exhibits the highest cell-type specificity in pancreatic epsilon cells, thereby representing the best candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among NDUFA3, PCMTD1, RRS1, PCDH20, and C6orf226 exhibits the highest cell-type specificity in pancreatic epsilon cells, thereby representing the best candidate for targeted intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the pancreatic epsilon cell-activated genes in PINNACLE to define the cell-type–specific targets for type 1 diabetes. Then, calculate the average embedding for this overlapping set and compute the cosine similarity between this reference and each individual target. If one gene exhibits a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TMPRSS11D', 'PDE8B', 'EXOC1', 'CSTB', 'NDUFS7']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFS7,"Among the genes TMPRSS11D, PDE8B, EXOC1, CSTB, and NDUFS7, which one exhibits the highest cell-type specificity in pancreatic epsilon cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Among the genes TMPRSS11D, PDE8B, EXOC1, CSTB, and NDUFS7, which one exhibits the highest cell-type specificity in pancreatic epsilon cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Then, determine which pancreatic epsilon cell–activated genes in PINNACLE overlap with these targets. Compute the average embedding of this overlapping set as a reference and calculate the cosine similarity between this reference and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PYDC2', 'PTDSS1', 'NDUFA1', 'HMGXB4', 'TACR1']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFA1,"Which gene among PYDC2, PTDSS1, NDUFA1, HMGXB4, and TACR1 exhibits the highest specificity in pancreatic epsilon cells for a potential target in type 1 diabetes mellitus?","Which gene among PYDC2, PTDSS1, NDUFA1, HMGXB4, and TACR1 exhibits the highest specificity in pancreatic epsilon cells for a potential target in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the genes activated in pancreatic epsilon cells within PINNACLE, thereby defining the cell-type–specific targets for type 1 diabetes. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference and each individual target. If one gene shows a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MMRN1', 'C1QL4', 'CASC23', 'RPS26', 'KTN1-AS1']",type 1 diabetes mellitus,pancreatic epsilon cell,RPS26,"Which gene among MMRN1, C1QL4, CASC23, RPS26, and KTN1-AS1 exhibits the highest specificity for pancreatic epsilon cells, thereby representing the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among MMRN1, C1QL4, CASC23, RPS26, and KTN1-AS1 exhibits the highest specificity for pancreatic epsilon cells, thereby representing the most promising candidate for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the pancreatic epsilon cell‐activated genes in PINNACLE to define a set of cell‐type–specific targets for type 1 diabetes. Compute the average embedding for this set as a reference, then calculate the cosine similarity between this reference and each individual gene’s embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence‐based explanation for its biological relevance."
"['PSMD7', 'NFATC1', 'ELMO3', 'CLNS1A', 'H1-4']",type 1 diabetes mellitus,pancreatic d cell,PSMD7,"Which gene among PSMD7, NFATC1, ELMO3, CLNS1A, and H1-4 exhibits the highest cell-type specificity in pancreatic delta cells for targeted intervention in type 1 diabetes mellitus?","Which gene among PSMD7, NFATC1, ELMO3, CLNS1A, and H1-4 exhibits the highest cell-type specificity in pancreatic delta cells for targeted intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Then, determine which of the pancreatic delta cell-activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific targets. Compute the average embedding for these genes and calculate the cosine similarity between this average and the embedding of each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SPTAN1', 'UBE2G1', 'LINC00461', 'BAX', 'ZNF532']",type 1 diabetes mellitus,pancreatic d cell,UBE2G1,"Which gene among SPTAN1, UBE2G1, LINC00461, BAX, and ZNF532 exhibits the greatest cell-type specificity in pancreatic delta cells, making it the optimal candidate for targeting in type 1 diabetes mellitus?","Which gene among SPTAN1, UBE2G1, LINC00461, BAX, and ZNF532 exhibits the greatest cell-type specificity in pancreatic delta cells, making it the optimal candidate for targeting in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE database. Determine the overlap between these targets and the genes activated in pancreatic d cells to define the cell-type–specific targets for type 1 diabetes. Next, compute the average embedding of this overlapping gene set and calculate the cosine similarity between this reference vector and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['INMT', 'PKMYT1', 'SEMA3C', 'BLTP1', 'PUS10']",type 1 diabetes mellitus,pancreatic d cell,BLTP1,"Among the genes INMT, PKMYT1, SEMA3C, BLTP1, and PUS10, which one exhibits the highest cell-type specificity in pancreatic delta cells for targeting type 1 diabetes mellitus?","Among the genes INMT, PKMYT1, SEMA3C, BLTP1, and PUS10, which one exhibits the highest cell-type specificity in pancreatic delta cells for targeting type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes and extract their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the set of pancreatic D cell–activated genes in PINNACLE to define cell-type–specific targets for type 1 diabetes. Compute the average embedding of this overlapping set, then calculate the cosine similarity between this average embedding and each individual target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['TLL2', 'LINC02752', 'LRP5', 'NDUFC1', 'SLITRK1']",type 1 diabetes mellitus,pancreatic d cell,NDUFC1,"Among the genes TLL2, LINC02752, LRP5, NDUFC1, and SLITRK1, which one demonstrates the highest cell-type specificity in pancreatic delta cells for targeting type 1 diabetes mellitus?","Among the genes TLL2, LINC02752, LRP5, NDUFC1, and SLITRK1, which one demonstrates the highest cell-type specificity in pancreatic delta cells for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the set of pancreatic d cell-activated genes in PINNACLE to define the cell-type–specific targets for the disease. Compute the average embedding of these overlapping targets, then calculate the cosine similarity between this average and each individual target. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['MCHR1', 'PPP1R9A', 'PTPN11', 'CREB3', 'BGLAP']",type 1 diabetes mellitus,pancreatic d cell,PTPN11,"Among the genes MCHR1, PPP1R9A, PTPN11, CREB3, and BGLAP, which one exhibits the highest cell-type-specific expression in pancreatic delta cells, making it the most promising target for type 1 diabetes mellitus intervention?","Among the genes MCHR1, PPP1R9A, PTPN11, CREB3, and BGLAP, which one exhibits the highest cell-type-specific expression in pancreatic delta cells, making it the most promising target for type 1 diabetes mellitus intervention? Identify and validate therapeutic targets for type 1 diabetes mellitus using the PINNACLE dataset by retrieving their cell-type–specific embeddings. Determine which of these targets overlap with genes specifically activated in pancreatic d cells, then compute the average embedding of this overlapping set as a reference. Calculate the cosine similarity between this reference embedding and each individual target, and if one gene shows markedly higher similarity than the others, nominate it as the prime candidate. Provide a concise, evidence-based explanation of its biological significance."
"['ENTHD1', 'FKBP1A', 'BGLAP', 'KLHDC10', 'GAST']",type 1 diabetes mellitus,pancreatic d cell,FKBP1A,"Among the genes ENTHD1, FKBP1A, BGLAP, KLHDC10, and GAST, which one exhibits the highest specificity for pancreatic delta cells in the context of targeting type 1 diabetes mellitus?","Among the genes ENTHD1, FKBP1A, BGLAP, KLHDC10, and GAST, which one exhibits the highest specificity for pancreatic delta cells in the context of targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, compare these targets with the pancreatic d cell-activated genes from PINNACLE to find overlapping genes, which will be considered the cell-type–specific targets for type 1 diabetes. Calculate the average embedding of these overlapping genes and then determine the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['F8A3', 'NDUFAF3', 'ATF7IP2', 'UBD', 'ZNF569']",type 1 diabetes mellitus,pancreatic d cell,NDUFAF3,"Which gene among F8A3, NDUFAF3, ATF7IP2, UBD, and ZNF569 exhibits the highest degree of cell-type specificity in pancreatic d cells for the therapeutic targeting of type 1 diabetes mellitus?","Which gene among F8A3, NDUFAF3, ATF7IP2, UBD, and ZNF569 exhibits the highest degree of cell-type specificity in pancreatic d cells for the therapeutic targeting of type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which pancreatic D cell–activated genes in PINNACLE overlap with these targets. For the overlapping gene set, compute the average embedding and then calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification of its biological relevance."
"['MBNL2', 'MUS81', 'PRKACG', 'HLA-A', 'C9orf40']",type 1 diabetes mellitus,pancreatic d cell,HLA-A,"Which gene—MBNL2, MUS81, PRKACG, HLA-A, or C9orf40—exhibits the highest specificity for pancreatic delta cells in the context of targeting type 1 diabetes mellitus?","Which gene—MBNL2, MUS81, PRKACG, HLA-A, or C9orf40—exhibits the highest specificity for pancreatic delta cells in the context of targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE resource. Next, determine which of these targets overlap with the pancreatic d cell-activated genes recorded in PINNACLE. For the overlapping group, compute the average embedding and then calculate the cosine similarity between this average and each individual gene’s embedding. If one gene exhibits significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological significance."
"['CACNA1D', 'SPRY2', 'MEFV', 'OPN3', 'TCF4-AS1']",type 1 diabetes mellitus,pancreatic d cell,CACNA1D,"Which gene—CACNA1D, SPRY2, MEFV, OPN3, or TCF4-AS1—exhibits the highest specificity to pancreatic delta cells as a potential target for type 1 diabetes mellitus?","Which gene—CACNA1D, SPRY2, MEFV, OPN3, or TCF4-AS1—exhibits the highest specificity to pancreatic delta cells as a potential target for type 1 diabetes mellitus? Which verified therapeutic targets for type 1 diabetes mellitus identified in PINNACLE overlap with the pancreatic d cell-activated genes? Retrieve the cell-type–specific embeddings for these overlapping targets, compute their average embedding, and then calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the primary candidate, providing a concise, evidence-based rationale for its biological relevance."
"['NDUFS5', 'TTC7A', 'THOC5', 'BLOC1S6', 'LINC01563']",type 1 diabetes mellitus,pancreatic d cell,NDUFS5,"Among the genes NDUFS5, TTC7A, THOC5, BLOC1S6, and LINC01563, which one exhibits the highest cell-type specificity in pancreatic delta cells for targeting type 1 diabetes mellitus?","Among the genes NDUFS5, TTC7A, THOC5, BLOC1S6, and LINC01563, which one exhibits the highest cell-type specificity in pancreatic delta cells for targeting type 1 diabetes mellitus? Identify verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the genes activated in pancreatic d cells within PINNACLE. From this overlapping set, compute the average embedding to serve as a reference, then calculate the cosine similarity between this reference and each individual target. If a single gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance in type 1 diabetes mellitus."
"['PWRN2', 'NDUFS4', 'SPRING1', 'LINC02801', 'UGT2B10']",type 1 diabetes mellitus,pancreatic d cell,NDUFS4,"Which gene among PWRN2, NDUFS4, SPRING1, LINC02801, and UGT2B10 exhibits the highest cell-type specificity in pancreatic delta cells for potential therapeutic targeting of type 1 diabetes mellitus?","Which gene among PWRN2, NDUFS4, SPRING1, LINC02801, and UGT2B10 exhibits the highest cell-type specificity in pancreatic delta cells for potential therapeutic targeting of type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with genes activated in pancreatic d cells. For the overlapping genes, compute the average embedding to serve as a reference, then calculate the cosine similarity between this reference and each individual gene’s embedding. Finally, nominate the gene with the highest cosine similarity as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['NDUFB2', 'IQGAP1', 'PDXK', 'COX7A1', 'MYT1']",type 1 diabetes mellitus,pancreatic d cell,NDUFB2,"Which gene among NDUFB2, IQGAP1, PDXK, COX7A1, and MYT1 exhibits the most selective expression in pancreatic delta cells, making it the optimal candidate for targeting type 1 diabetes mellitus?","Which gene among NDUFB2, IQGAP1, PDXK, COX7A1, and MYT1 exhibits the most selective expression in pancreatic delta cells, making it the optimal candidate for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of the pancreatic d cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for type 1 diabetes. Compute the average embedding of these overlapping genes and then calculate the cosine similarity between this average and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['EGLN2', 'ARAP1-AS1', 'SPC24', 'AMZ2', 'PRRG4']",type 1 diabetes mellitus,pancreatic d cell,AMZ2,"Among the genes EGLN2, ARAP1-AS1, SPC24, AMZ2, and PRRG4, which one exhibits the highest cell-type specificity in pancreatic delta cells, indicating its potential as a therapeutic target for type 1 diabetes mellitus?","Among the genes EGLN2, ARAP1-AS1, SPC24, AMZ2, and PRRG4, which one exhibits the highest cell-type specificity in pancreatic delta cells, indicating its potential as a therapeutic target for type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which activated pancreatic d cell genes in PINNACLE overlap with these targets to define the cell-type–specific targets for type 1 diabetes. Compute the average embedding for this overlapping gene set to serve as a reference, then calculate the cosine similarity between this reference and each individual target gene’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['VPS72', 'APMAP', 'HCFC1', 'CUL4B', 'ASCL2']",type 1 diabetes mellitus,pancreatic d cell,ASCL2,"Which gene among VPS72, APMAP, HCFC1, CUL4B, and ASCL2 demonstrates the highest cell-type specificity in pancreatic d cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among VPS72, APMAP, HCFC1, CUL4B, and ASCL2 demonstrates the highest cell-type specificity in pancreatic d cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell‐type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the genes activated in pancreatic d cells in PINNACLE, designating this overlap as the cell‐type–specific targets for type 1 diabetes. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target gene. If one gene consistently shows a markedly higher similarity than the others, nominate it as the top candidate gene and provide a concise, evidence-based rationale supporting its biological relevance."
"['TOGARAM2', 'GRB14', 'TMEM39A', 'ZNF337', 'MAL2']",type 1 diabetes mellitus,pancreatic d cell,MAL2,"Among the genes TOGARAM2, GRB14, TMEM39A, ZNF337, and MAL2, which one exhibits the highest cell-type specificity in pancreatic delta cells for potential targeting in type 1 diabetes mellitus?","Among the genes TOGARAM2, GRB14, TMEM39A, ZNF337, and MAL2, which one exhibits the highest cell-type specificity in pancreatic delta cells for potential targeting in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which pancreatic d cell-activated genes overlap with these targets, thereby defining a subset of cell-type–specific therapeutic targets. Compute the average embedding for this subset and calculate the cosine similarity between this reference embedding and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DEXI', 'DRC7', 'OAZ3', 'BTG3', 'ASF1A']",type 1 diabetes mellitus,pancreatic d cell,DEXI,"Among the genes DEXI, DRC7, OAZ3, BTG3, and ASF1A, which one exhibits the highest cell-type specificity in pancreatic delta cells for targeting type 1 diabetes mellitus?","Among the genes DEXI, DRC7, OAZ3, BTG3, and ASF1A, which one exhibits the highest cell-type specificity in pancreatic delta cells for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and collect their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the genes activated in pancreatic d cells from PINNACLE. Compute the average embedding for the overlapping set, then calculate the cosine similarity between this average and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['STON2', 'C2orf15', 'LINC01526', 'LEMD1', 'LIMCH1']",type 1 diabetes mellitus,pancreatic d cell,LIMCH1,"Which gene among STON2, C2orf15, LINC01526, LEMD1, and LIMCH1 exhibits the highest cell-type–specific expression in pancreatic delta cells, potentially making it the optimal target for type 1 diabetes mellitus interventions?","Which gene among STON2, C2orf15, LINC01526, LEMD1, and LIMCH1 exhibits the highest cell-type–specific expression in pancreatic delta cells, potentially making it the optimal target for type 1 diabetes mellitus interventions? Identify verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the pancreatic d cell–activated genes in PINNACLE, defining the resulting set as the cell-type–specific targets for type 1 diabetes. Calculate their average embedding to serve as a reference, and then compute the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['IFT74', 'FYB2', 'PFDN6', 'IGFBP7', 'DDIT4L']",type 1 diabetes mellitus,pancreatic d cell,IGFBP7,"Which gene—IFT74, FYB2, PFDN6, IGFBP7, or DDIT4L—exhibits the highest cell-type specificity in pancreatic delta cells relevant to type 1 diabetes mellitus?","Which gene—IFT74, FYB2, PFDN6, IGFBP7, or DDIT4L—exhibits the highest cell-type specificity in pancreatic delta cells relevant to type 1 diabetes mellitus? What are the validated therapeutic targets for type 1 diabetes mellitus, and what are their corresponding cell-type–specific embeddings in the PINNACLE dataset? Identify which of these targets overlap with the pancreatic d-cell activated genes in PINNACLE. Compute the average embedding for the overlapping set, then determine the cosine similarity between this averaged embedding and that of each individual target. If one gene shows significantly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance to type 1 diabetes mellitus."
"['MMP8', 'RPS6', 'ITM2A', 'TARS3', 'CDKN2A']",type 1 diabetes mellitus,pancreatic d cell,CDKN2A,"Which gene among MMP8, RPS6, ITM2A, TARS3, and CDKN2A exhibits the highest cell-type specificity in pancreatic δ cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among MMP8, RPS6, ITM2A, TARS3, and CDKN2A exhibits the highest cell-type specificity in pancreatic δ cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which pancreatic d cell–activated genes overlap with these targets to define a set of cell-type–specific targets. Calculate the average embedding of this set as a reference and then compute the cosine similarity between this reference and each target's embedding. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['MTCL1', 'LINC01975', 'IMPDH2', 'ADGRE5', 'FAM87A']",type 1 diabetes mellitus,pancreatic d cell,IMPDH2,"Which gene among MTCL1, LINC01975, IMPDH2, ADGRE5, and FAM87A exhibits the highest cell-type specificity in pancreatic d cells for targeting type 1 diabetes mellitus?","Which gene among MTCL1, LINC01975, IMPDH2, ADGRE5, and FAM87A exhibits the highest cell-type specificity in pancreatic d cells for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE database. Then, determine which genes activated in pancreatic d cells in PINNACLE overlap with these targets to define the cell-type–specific targets for type 1 diabetes. Compute the average embedding of this overlapping set as a reference and calculate the cosine similarity between this reference and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate, and provide a concise, evidence-based rationale for its biological relevance."
"['MRPL18', 'TNF', 'ROPN1', 'SDC4', 'EIF3H']",type 1 diabetes mellitus,pancreatic ductal cell,TNF,"Among the genes MRPL18, TNF, ROPN1, SDC4, and EIF3H, which one exhibits the highest cell-type specificity in pancreatic ductal cells, making it the most suitable candidate for targeted interventions in type 1 diabetes mellitus?","Among the genes MRPL18, TNF, ROPN1, SDC4, and EIF3H, which one exhibits the highest cell-type specificity in pancreatic ductal cells, making it the most suitable candidate for targeted interventions in type 1 diabetes mellitus? Identify all validated therapeutic targets for type 1 diabetes mellitus that have cell-type–specific embeddings in PINNACLE. Next, determine which of these targets overlap with the set of pancreatic ductal cell–activated genes in PINNACLE. Compute the average embedding for these overlapping genes and calculate the cosine similarity between this average embedding and the embedding of each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['IL6-AS1', 'LCE1E', 'OPCML', 'NDUFB5', 'SFSWAP']",type 1 diabetes mellitus,pancreatic ductal cell,NDUFB5,"Which gene among IL6-AS1, LCE1E, OPCML, NDUFB5, and SFSWAP exhibits the highest specificity for pancreatic ductal cells, thereby representing the most promising candidate target for type 1 diabetes mellitus?","Which gene among IL6-AS1, LCE1E, OPCML, NDUFB5, and SFSWAP exhibits the highest specificity for pancreatic ductal cells, thereby representing the most promising candidate target for type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which genes that are activated in pancreatic ductal cells in PINNACLE overlap with these validated targets. Calculate the average embedding of this overlapping set as a reference, then compute the cosine similarity between this reference and the embedding of each target. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LINC02585', 'TGFB2-AS1', 'OXCT2', 'FGGY', 'ACOT6']",type 1 diabetes mellitus,pancreatic ductal cell,FGGY,"Which gene among LINC02585, TGFB2-AS1, OXCT2, FGGY, and ACOT6 exhibits the highest cell-type specificity in pancreatic ductal cells for targeted intervention in type 1 diabetes mellitus?","Which gene among LINC02585, TGFB2-AS1, OXCT2, FGGY, and ACOT6 exhibits the highest cell-type specificity in pancreatic ductal cells for targeted intervention in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which genes upregulated in pancreatic ductal cells (as defined by PINNACLE) overlap with these targets, thereby establishing the cell-type–specific targets for type 1 diabetes. Compute the average embedding of this overlapping set, then calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TMEM91', 'FAM227B', 'MTFMT', 'SELENBP1', 'ATXN2']",type 1 diabetes mellitus,pancreatic ductal cell,ATXN2,"Among the genes TMEM91, FAM227B, MTFMT, SELENBP1, and ATXN2, which exhibits the highest specificity in pancreatic ductal cells for potential targeting in type 1 diabetes mellitus?","Among the genes TMEM91, FAM227B, MTFMT, SELENBP1, and ATXN2, which exhibits the highest specificity in pancreatic ductal cells for potential targeting in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the genes activated in pancreatic ductal cells in PINNACLE to define a set of cell-type–specific targets for type 1 diabetes. Compute the average embedding of this set as a reference, then calculate the cosine similarity between the reference and each individual target gene. If one gene has a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its relevance."
"['IGBP1-AS2', 'RNF216', 'CFAP61', 'LINC01553', 'AIFM2']",type 1 diabetes mellitus,pancreatic ductal cell,RNF216,"Which of the following genes—IGBP1-AS2, RNF216, CFAP61, LINC01553, or AIFM2—exhibits the most specific expression in pancreatic ductal cells, making it the strongest candidate for targeting type 1 diabetes mellitus?","Which of the following genes—IGBP1-AS2, RNF216, CFAP61, LINC01553, or AIFM2—exhibits the most specific expression in pancreatic ductal cells, making it the strongest candidate for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE database. Next, find the overlap between these targets and the pancreatic ductal cell-activated genes in PINNACLE. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference embedding and the embedding of each target gene. If one gene shows a significantly higher cosine similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZMYND15', 'ABHD3', 'RPGRIP1L', 'ACTR2', 'ABCG2']",type 1 diabetes mellitus,pancreatic ductal cell,RPGRIP1L,"Among ZMYND15, ABHD3, RPGRIP1L, ACTR2, and ABCG2, which gene exhibits the most cell-type specific expression in pancreatic ductal cells for potential targeting in type 1 diabetes mellitus?","Among ZMYND15, ABHD3, RPGRIP1L, ACTR2, and ABCG2, which gene exhibits the most cell-type specific expression in pancreatic ductal cells for potential targeting in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with genes activated in pancreatic ductal cells, as these overlapping genes represent cell-type–specific targets for the disease. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this average embedding and each individual target’s embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TRIB2', 'SLC25A45', 'IDI1', 'CDK6-AS1', 'AHSA1']",type 1 diabetes mellitus,pancreatic ductal cell,TRIB2,"Among the genes TRIB2, SLC25A45, IDI1, CDK6-AS1, and AHSA1, which one exhibits the highest cell-type specificity in pancreatic ductal cells, making it the most suitable target for type 1 diabetes mellitus interventions?","Among the genes TRIB2, SLC25A45, IDI1, CDK6-AS1, and AHSA1, which one exhibits the highest cell-type specificity in pancreatic ductal cells, making it the most suitable target for type 1 diabetes mellitus interventions? Identify and validate therapeutic targets for type 1 diabetes mellitus and obtain their corresponding cell-type-specific embeddings from PINNACLE. Determine which pancreatic ductal cell-activated genes overlap with these targets to define a set of cell-type-specific targets. Calculate the average embedding of these targets as a reference, then compute the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['CLIC1', 'CGN', 'MYOSLID', 'NIT1', 'WDR26']",type 1 diabetes mellitus,pancreatic ductal cell,CLIC1,"Among the genes CLIC1, CGN, MYOSLID, NIT1, and WDR26, which one exhibits the highest cell-type specificity in pancreatic ductal cells and represents the most promising target for type 1 diabetes mellitus intervention?","Among the genes CLIC1, CGN, MYOSLID, NIT1, and WDR26, which one exhibits the highest cell-type specificity in pancreatic ductal cells and represents the most promising target for type 1 diabetes mellitus intervention? For type 1 diabetes mellitus, first identify verified therapeutic target genes and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the genes activated in pancreatic ductal cells as represented in PINNACLE. Treat this overlapping set as the cell-type–specific targets for the disease. Compute the average embedding vector of these genes and then calculate the cosine similarity between this average vector and the embedding for each individual target. If one gene shows a markedly higher similarity relative to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LIMCH1', 'PSMF1', 'VPS13B-DT', 'LINC02525', 'GUCY1B1']",type 1 diabetes mellitus,pancreatic ductal cell,LIMCH1,"Which gene among LIMCH1, PSMF1, VPS13B-DT, LINC02525, and GUCY1B1 exhibits the highest cell-type specificity in pancreatic ductal cells for the purpose of targeting type 1 diabetes mellitus?","Which gene among LIMCH1, PSMF1, VPS13B-DT, LINC02525, and GUCY1B1 exhibits the highest cell-type specificity in pancreatic ductal cells for the purpose of targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, compare these targets with the pancreatic ductal cell–activated genes in PINNACLE to determine the overlapping set, which will represent the cell-type–specific therapeutic targets for type 1 diabetes. Compute the average embedding of these overlapping targets and then calculate the cosine similarity between this reference embedding and each individual target. If a single gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MT-ND4', 'TPRG1-AS1', 'UBXN7-AS1', 'HMBOX1', 'TMBIM6']",type 1 diabetes mellitus,pancreatic ductal cell,MT-ND4,"Which candidate gene—MT-ND4, TPRG1-AS1, UBXN7-AS1, HMBOX1, or TMBIM6—displays the highest cell-type specificity in pancreatic ductal cells for the targeted intervention of type 1 diabetes mellitus?","Which candidate gene—MT-ND4, TPRG1-AS1, UBXN7-AS1, HMBOX1, or TMBIM6—displays the highest cell-type specificity in pancreatic ductal cells for the targeted intervention of type 1 diabetes mellitus? Identify verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type-specific embeddings from PINNACLE. Next, determine which of the pancreatic ductal cell-activated genes in PINNACLE overlap with these targets, designating this intersection as the cell-type-specific targets for type 1 diabetes. Compute the mean embedding of this intersecting set and then calculate the cosine similarity between the mean embedding and each individual target's embedding. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a succinct, evidence-based rationale for its biological relevance."
"['MRM3', 'INSR', 'FCHSD2', 'EVPL', 'SRARP']",type 1 diabetes mellitus,pancreatic ductal cell,INSR,"Among the genes MRM3, INSR, FCHSD2, EVPL, and SRARP, which exhibits the highest cell-type-specific expression in pancreatic ductal cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Among the genes MRM3, INSR, FCHSD2, EVPL, and SRARP, which exhibits the highest cell-type-specific expression in pancreatic ductal cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Then, determine which of these targets overlap with the PINNACLE-identified pancreatic ductal cell–activated genes. For the overlapping set, compute the average embedding as a reference and calculate the cosine similarity between this average and each individual target embedding. If one gene consistently exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SLC26A8', 'SDHD', 'C13orf46', 'PCDHGB2', 'MAGI3']",type 1 diabetes mellitus,pancreatic ductal cell,MAGI3,"Which gene among SLC26A8, SDHD, C13orf46, PCDHGB2, and MAGI3 demonstrates the highest cell-type specificity in pancreatic ductal cells for targeting Type 1 diabetes mellitus?","Which gene among SLC26A8, SDHD, C13orf46, PCDHGB2, and MAGI3 demonstrates the highest cell-type specificity in pancreatic ductal cells for targeting Type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE dataset. Then, determine which of these targets overlap with genes activated in pancreatic ductal cells, thereby defining a set of cell-type–specific targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference and each individual target’s embedding. Finally, nominate the gene with a markedly higher similarity as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['GMPPA', 'TAP1', 'UGT2B15', 'MYCBPAP', 'NGDN']",type 1 diabetes mellitus,pancreatic ductal cell,TAP1,"Which gene among GMPPA, TAP1, UGT2B15, MYCBPAP, and NGDN exhibits the highest cell type-specific expression in pancreatic ductal cells, thereby representing the most promising target for therapeutic intervention in type 1 diabetes mellitus?","Which gene among GMPPA, TAP1, UGT2B15, MYCBPAP, and NGDN exhibits the highest cell type-specific expression in pancreatic ductal cells, thereby representing the most promising target for therapeutic intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes and extract their cell-type-specific embeddings from the PINNACLE dataset. Next, determine the overlap between these targets and the pancreatic ductal cell-activated genes in PINNACLE to define the cell-type-specific targets for type 1 diabetes. Compute the average embedding of this overlapping set and calculate the cosine similarity between this reference and the embedding of each individual target. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['INTS4', 'CYP2C18', 'ANKRD34C-AS1', 'BNC2', 'SMIM20']",type 1 diabetes mellitus,pancreatic ductal cell,SMIM20,"Among the genes INTS4, CYP2C18, ANKRD34C-AS1, BNC2, and SMIM20, which one exhibits the highest cell-type specificity in pancreatic ductal cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Among the genes INTS4, CYP2C18, ANKRD34C-AS1, BNC2, and SMIM20, which one exhibits the highest cell-type specificity in pancreatic ductal cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Identify confirmed therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which targets overlap with genes activated in pancreatic ductal cells, producing a set of cell-type–specific targets. Compute the average embedding of this subset and calculate the cosine similarity between each target’s embedding and this average. If one gene exhibits a distinctly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['HNRNPH3', 'GRPEL1', 'PPP1R15A', 'HLA-DMB', 'CHMP7']",type 1 diabetes mellitus,pancreatic ductal cell,HLA-DMB,"Among the genes HNRNPH3, GRPEL1, PPP1R15A, HLA-DMB, and CHMP7, which one exhibits the highest specificity for pancreatic ductal cells, making it the most promising target for type 1 diabetes mellitus?","Among the genes HNRNPH3, GRPEL1, PPP1R15A, HLA-DMB, and CHMP7, which one exhibits the highest specificity for pancreatic ductal cells, making it the most promising target for type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the genes activated in pancreatic ductal cells in PINNACLE to establish a subset of cell-type–specific targets. Compute the average embedding for this subset and calculate the cosine similarity between this average and each target's embedding. If one gene shows a significantly higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PSG8', 'C1QBP', 'RAX2', 'ZNF329', 'PSMD7']",type 1 diabetes mellitus,pancreatic ductal cell,PSMD7,"Which gene among PSG8, C1QBP, RAX2, ZNF329, and PSMD7 exhibits the highest specificity for pancreatic ductal cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among PSG8, C1QBP, RAX2, ZNF329, and PSMD7 exhibits the highest specificity for pancreatic ductal cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which genes activated in pancreatic ductal cells overlap with these targets, thereby defining the cell-type–specific targets for type 1 diabetes. Calculate the average embedding for this overlapping set and compute the cosine similarity between this average and each individual target’s embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['AGO3', 'BCAR3-AS1', 'ADGRG4', 'MINAR1', 'LINC02433']",type 1 diabetes mellitus,pancreatic ductal cell,AGO3,"Which gene among AGO3, BCAR3-AS1, ADGRG4, MINAR1, and LINC02433 exhibits the highest cell-type specificity in pancreatic ductal cells in relation to type 1 diabetes mellitus?","Which gene among AGO3, BCAR3-AS1, ADGRG4, MINAR1, and LINC02433 exhibits the highest cell-type specificity in pancreatic ductal cells in relation to type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Then, determine which of these targets overlap with genes activated in pancreatic ductal cells. For the overlapping set, calculate the average embedding to serve as a reference and compute the cosine similarity between this reference and each individual target embedding. If one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GUCA1C', 'SYBU', 'UCHL3', 'TMEM170A', 'WDFY3']",type 1 diabetes mellitus,pancreatic ductal cell,UCHL3,"Which gene among GUCA1C, SYBU, UCHL3, TMEM170A, and WDFY3 exhibits the highest specificity for pancreatic ductal cells as a potential target for type 1 diabetes mellitus therapy?","Which gene among GUCA1C, SYBU, UCHL3, TMEM170A, and WDFY3 exhibits the highest specificity for pancreatic ductal cells as a potential target for type 1 diabetes mellitus therapy? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the genes activated in pancreatic ductal cells within PINNACLE. Compute the mean embedding of this overlapping gene set and then calculate the cosine similarity of each individual embedding against this mean. Designate the gene with a markedly higher similarity as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MRPL4', 'CARMIL1', 'PCK2', 'PIGT', 'CLDN25']",type 1 diabetes mellitus,pancreatic ductal cell,CARMIL1,"Which gene among MRPL4, CARMIL1, PCK2, PIGT, and CLDN25 exhibits the highest cell-type–specific expression in pancreatic ductal cells, making it the most promising candidate for targeted research in type 1 diabetes mellitus?","Which gene among MRPL4, CARMIL1, PCK2, PIGT, and CLDN25 exhibits the highest cell-type–specific expression in pancreatic ductal cells, making it the most promising candidate for targeted research in type 1 diabetes mellitus? Retrieve the list of verified therapeutic targets for type 1 diabetes mellitus along with their corresponding cell-type-specific embeddings from PINNACLE. Next, identify which of these targets overlap with the set of pancreatic ductal cell-activated genes provided by PINNACLE, thereby defining the cell-type-specific targets for type 1 diabetes mellitus. Compute the average embedding vector for this overlapping group and assess the cosine similarity between this average and the individual target embeddings. If one gene exhibits a distinctly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GSN', 'SMCR2', 'ZNF146', 'ATF4', 'CC2D1B']",type 1 diabetes mellitus,pancreatic ductal cell,GSN,"Which gene among GSN, SMCR2, ZNF146, ATF4, and CC2D1B exhibits the highest specificity in pancreatic ductal cells for potential therapeutic targeting in type 1 diabetes mellitus?","Which gene among GSN, SMCR2, ZNF146, ATF4, and CC2D1B exhibits the highest specificity in pancreatic ductal cells for potential therapeutic targeting in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type-specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with genes activated in pancreatic ductal cells, thereby defining the cell-type-specific targets for type 1 diabetes. Compute the average embedding of these overlapping targets and calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LINC01063', 'PIGF', 'USP16', 'NDUFA13', 'MBD4']",type 1 diabetes mellitus,endothelial cell,NDUFA13,"Among the genes LINC01063, PIGF, USP16, NDUFA13, and MBD4, which exhibits the most endothelial cell-specific expression for targeted intervention in type 1 diabetes mellitus?","Among the genes LINC01063, PIGF, USP16, NDUFA13, and MBD4, which exhibits the most endothelial cell-specific expression for targeted intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which endothelial cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific target set for type 1 diabetes. Compute the average embedding for this set, then calculate the cosine similarity between this average and each individual target embedding. If one gene shows a significantly higher similarity than all others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological significance in type 1 diabetes mellitus."
"['H4C3', 'MAGI1-AS1', 'PIEZO2', 'CNIH3-AS1', 'RPL27']",type 1 diabetes mellitus,endothelial cell,H4C3,"Among the genes H4C3, MAGI1-AS1, PIEZO2, CNIH3-AS1, and RPL27, which exhibits the highest degree of endothelial cell-specific expression, making it the strongest candidate for targeting type 1 diabetes mellitus?","Among the genes H4C3, MAGI1-AS1, PIEZO2, CNIH3-AS1, and RPL27, which exhibits the highest degree of endothelial cell-specific expression, making it the strongest candidate for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets intersect with the endothelial cell-activated genes in the database, yielding a set of cell-type–specific targets. Calculate the average embedding of this overlapping gene set to serve as a reference, then compute the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the rest, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['OR2L2', 'ANKRD45', 'NDUFA6', 'OAS1', 'OLR1']",type 1 diabetes mellitus,endothelial cell,NDUFA6,"Which gene among OR2L2, ANKRD45, NDUFA6, OAS1, and OLR1 exhibits the highest endothelial cell specificity for targeting type 1 diabetes mellitus?","Which gene among OR2L2, ANKRD45, NDUFA6, OAS1, and OLR1 exhibits the highest endothelial cell specificity for targeting type 1 diabetes mellitus? Which verified therapeutic targets for type 1 diabetes mellitus overlap with the endothelial cell-activated genes in the PINNACLE database? Retrieve the cell-type–specific embeddings for these overlapping targets, compute their average embedding as a reference, and then calculate the cosine similarity between this reference and each individual target's embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['EPHA2', 'MT-ND4L', 'LHFPL6', 'PLEKHB1', 'PCDH10']",type 1 diabetes mellitus,endothelial cell,MT-ND4L,"Among EPHA2, MT-ND4L, LHFPL6, PLEKHB1, and PCDH10, which gene exhibits the highest endothelial cell-type specificity in the context of type 1 diabetes mellitus for targeted intervention?","Among EPHA2, MT-ND4L, LHFPL6, PLEKHB1, and PCDH10, which gene exhibits the highest endothelial cell-type specificity in the context of type 1 diabetes mellitus for targeted intervention? Which verified therapeutic targets for type 1 diabetes have cell-type–specific representations in PINNACLE, and which of these overlap with the endothelial cell-activated genes? For the overlapping set, compute the average embedding and then determine the cosine similarity between this reference embedding and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['BRD2', 'ARL14EP', 'DNAH5', 'TTC9B', 'TTC6']",type 1 diabetes mellitus,endothelial cell,BRD2,"Which gene among BRD2, ARL14EP, DNAH5, TTC9B, and TTC6 exhibits the highest endothelial cell-type specificity for targeting type 1 diabetes mellitus?","Which gene among BRD2, ARL14EP, DNAH5, TTC9B, and TTC6 exhibits the highest endothelial cell-type specificity for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which endothelial cell-activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific targets. Compute the average embedding of this set as a reference, and then calculate the cosine similarity between the reference and each target’s embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CFI', 'KDR', 'PRNT', 'NUP133', 'RPL35']",type 1 diabetes mellitus,endothelial cell,KDR,"Which gene, among CFI, KDR, PRNT, NUP133, and RPL35, exhibits the highest endothelial cell-type specificity for potential targeting in type 1 diabetes mellitus?","Which gene, among CFI, KDR, PRNT, NUP133, and RPL35, exhibits the highest endothelial cell-type specificity for potential targeting in type 1 diabetes mellitus? Using verified therapeutic targets for type 1 diabetes mellitus, obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, identify which of these targets overlap with the endothelial cell-activated genes in PINNACLE. Compute the average embedding for this overlapping set and then calculate the cosine similarity between this average and each individual target’s embedding. If one target exhibits a notably higher similarity than the others, nominate it as the top candidate, and provide a concise, evidence-based rationale for its biological relevance."
"['APP-DT', 'EDNRB', 'GIMAP7', 'TTF1', 'CLHC1']",type 1 diabetes mellitus,endothelial cell,EDNRB,"Which gene among APP-DT, EDNRB, GIMAP7, TTF1, and CLHC1 exhibits the highest specificity for endothelial cells, thereby representing the best candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among APP-DT, EDNRB, GIMAP7, TTF1, and CLHC1 exhibits the highest specificity for endothelial cells, thereby representing the best candidate for targeted intervention in type 1 diabetes mellitus? Identify experimentally validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which endothelial cell‐activated genes in PINNACLE overlap with these targets to define a diabetes-related, cell-specific target set. Calculate the average embedding of this set, then compute the cosine similarity between this average and the individual embeddings of each target gene. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ATXN7L3B', 'FOXA1', 'GJB7', 'SH3GL2', 'XRCC5']",type 1 diabetes mellitus,endothelial cell,ATXN7L3B,"Which gene among ATXN7L3B, FOXA1, GJB7, SH3GL2, and XRCC5 exhibits the most specific expression in endothelial cells, making it the optimal candidate for targeting type 1 diabetes mellitus?","Which gene among ATXN7L3B, FOXA1, GJB7, SH3GL2, and XRCC5 exhibits the most specific expression in endothelial cells, making it the optimal candidate for targeting type 1 diabetes mellitus? Identify the confirmed therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which endothelial cell-activated genes in PINNACLE overlap with these therapeutic targets to define the cell-type–specific targets for T1DM. Calculate the average embedding for this overlapping set and compute the cosine similarity between this average and each individual target's embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SASH1', 'DIPK1B', 'ARHGAP26', 'NUPR1', 'KLHDC8B']",type 1 diabetes mellitus,endothelial cell,NUPR1,"Among the genes SASH1, DIPK1B, ARHGAP26, NUPR1, and KLHDC8B, which one exhibits the highest endothelial cell-type specificity in relation to type 1 diabetes mellitus?","Among the genes SASH1, DIPK1B, ARHGAP26, NUPR1, and KLHDC8B, which one exhibits the highest endothelial cell-type specificity in relation to type 1 diabetes mellitus? Using the PINNACLE database, identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings. Next, determine which endothelial cell-activated genes in PINNACLE overlap with these targets, thereby defining a set of cell-type–specific targets for the disease. Compute the average embedding of this set and calculate the cosine similarity between this reference vector and the embedding of each individual target. If one gene exhibits a markedly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZNF330', 'DUSP4', 'DNAH12', 'ADPRS', 'MTCH1']",type 1 diabetes mellitus,endothelial cell,MTCH1,"Among the genes ZNF330, DUSP4, DNAH12, ADPRS, and MTCH1, which one exhibits the highest endothelial cell specificity for targeted approaches in type 1 diabetes mellitus?","Among the genes ZNF330, DUSP4, DNAH12, ADPRS, and MTCH1, which one exhibits the highest endothelial cell specificity for targeted approaches in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, find the overlap between these targets and the endothelial cell-activated genes recorded in PINNACLE, representing the cell-type–specific targets for type 1 diabetes. Compute the average embedding of this overlapping set, then determine the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['KISS1', 'BMT2', 'CCDC9B', 'NDUFS5', 'SPC24']",type 1 diabetes mellitus,endothelial cell,NDUFS5,"Which gene among KISS1, BMT2, CCDC9B, NDUFS5, and SPC24 exhibits the highest specificity for endothelial cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among KISS1, BMT2, CCDC9B, NDUFS5, and SPC24 exhibits the highest specificity for endothelial cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from the PINNACLE database. From these, select the targets that are activated in endothelial cells, compute their average embedding as a reference, and calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['ZNF433', 'C4orf46', 'NDUFC1', 'HECW2', 'C5']",type 1 diabetes mellitus,endothelial cell,NDUFC1,"Which gene among ZNF433, C4orf46, NDUFC1, HECW2, and C5 exhibits the highest endothelial cell specificity relevant to type 1 diabetes mellitus?","Which gene among ZNF433, C4orf46, NDUFC1, HECW2, and C5 exhibits the highest endothelial cell specificity relevant to type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with the set of endothelial cell-activated genes from the same dataset, representing potential cell-type–specific targets for the disease. Calculate the average embedding for this overlapping set, and then compute the cosine similarity between this average and the embedding for each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HPX', 'CDK16', 'KLF3', 'TXNRD2', 'PYROXD1']",type 1 diabetes mellitus,endothelial cell,KLF3,"Among the genes HPX, CDK16, KLF3, TXNRD2, and PYROXD1, which one exhibits the greatest endothelial cell-type specificity relevant to therapeutic targeting of type 1 diabetes mellitus?","Among the genes HPX, CDK16, KLF3, TXNRD2, and PYROXD1, which one exhibits the greatest endothelial cell-type specificity relevant to therapeutic targeting of type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, from the set of endothelial cell-activated genes in PINNACLE, determine which ones overlap with these targets. Calculate the average embedding of this overlapping set to serve as a reference, then compute the cosine similarity between this reference and each individual target. If one gene shows a clearly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based explanation for its biological relevance."
"['NADK', 'ASAP1', 'BHLHA15', 'TTLL1-AS1', 'RPL17']",type 1 diabetes mellitus,endothelial cell,ASAP1,"Among NADK, ASAP1, BHLHA15, TTLL1-AS1, and RPL17, which gene exhibits the highest endothelial cell-specific expression relevant to targeted interventions for type 1 diabetes mellitus?","Among NADK, ASAP1, BHLHA15, TTLL1-AS1, and RPL17, which gene exhibits the highest endothelial cell-specific expression relevant to targeted interventions for type 1 diabetes mellitus? Identify the validated therapeutic target genes for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, intersect these targets with the set of endothelial cell–activated genes to define the cell-type–specific therapeutic targets. Compute the average embedding of this overlapping set and, for each target, calculate the cosine similarity between its embedding and the average. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CBFA2T2', 'JAK1', 'ARHGEF2-AS2', 'SCAMP1', 'LEKR1']",type 1 diabetes mellitus,endothelial cell,JAK1,"Which gene among CBFA2T2, JAK1, ARHGEF2-AS2, SCAMP1, and LEKR1 exhibits the greatest specificity for endothelial cells in the context of targeting type 1 diabetes mellitus?","Which gene among CBFA2T2, JAK1, ARHGEF2-AS2, SCAMP1, and LEKR1 exhibits the greatest specificity for endothelial cells in the context of targeting type 1 diabetes mellitus? Using a set of verified therapeutic targets for type 1 diabetes mellitus, retrieve their cell-type–specific embeddings from PINNACLE. Identify the targets that intersect with the endothelial cell-activated genes in PINNACLE to define the relevant cell-type–specific candidate genes. Next, compute the average embedding of these candidates and determine the cosine similarity between this reference and each individual embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the primary candidate and provide a concise, evidence-based rationale for its biological relevance in type 1 diabetes mellitus."
"['CHMP7', 'OR1N2', 'CTBP2', 'ZNF701', 'SLC24A4']",type 1 diabetes mellitus,endothelial cell,CTBP2,"Among the genes CHMP7, OR1N2, CTBP2, ZNF701, and SLC24A4, which one demonstrates the highest specificity in endothelial cells for potential therapeutic targeting of type 1 diabetes mellitus?","Among the genes CHMP7, OR1N2, CTBP2, ZNF701, and SLC24A4, which one demonstrates the highest specificity in endothelial cells for potential therapeutic targeting of type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with the endothelial cell‐activated genes catalogued in PINNACLE. Compute the average embedding of the overlapping set as a reference profile, and then calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in type 1 diabetes mellitus."
"['MRPL37', 'SPOCD1', 'GNG7', 'NDUFB2', 'S100A5']",type 1 diabetes mellitus,endothelial cell,NDUFB2,"Among MRPL37, SPOCD1, GNG7, NDUFB2, and S100A5, which gene demonstrates the highest endothelial cell-specific expression and is therefore the most promising candidate for targeting type 1 diabetes mellitus?","Among MRPL37, SPOCD1, GNG7, NDUFB2, and S100A5, which gene demonstrates the highest endothelial cell-specific expression and is therefore the most promising candidate for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the endothelial cell–activated genes in PINNACLE to define the cell-type–specific targets for this condition. Calculate the average embedding for these overlapping targets and compute the cosine similarity between this average embedding and each individual target. If one gene exhibits a significantly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CNPY3', 'PRKACA', 'CLEC14A', 'PCDHAC2', 'CD44']",type 1 diabetes mellitus,endothelial cell,CD44,"Which gene among CNPY3, PRKACA, CLEC14A, PCDHAC2, and CD44 exhibits the highest endothelial cell-specific expression for potential targeting in type 1 diabetes mellitus?","Which gene among CNPY3, PRKACA, CLEC14A, PCDHAC2, and CD44 exhibits the highest endothelial cell-specific expression for potential targeting in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE resource. Next, determine which endothelial cell-activated genes in PINNACLE overlap with these verified targets. Calculate the average embedding of this overlapping set to serve as a reference, and then compute the cosine similarity between the reference and each individual target. If one gene displays a markedly higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RAB42', 'GPKOW', 'NDUFC2', 'LINC00681', 'DRAP1']",type 1 diabetes mellitus,endothelial cell,NDUFC2,"Which gene among RAB42, GPKOW, NDUFC2, LINC00681, and DRAP1 exhibits the highest endothelial cell-specific expression relevant for targeting type 1 diabetes mellitus?","Which gene among RAB42, GPKOW, NDUFC2, LINC00681, and DRAP1 exhibits the highest endothelial cell-specific expression relevant for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes and retrieve their cell-type-specific embeddings from the PINNACLE database. Next, determine which endothelial cell-activated genes in PINNACLE overlap with these targets to establish a candidate set. Calculate the average embedding of these candidates, then compute the cosine similarity between this average and each individual candidate's embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['LINC02361', 'EVA1C', 'SMPDL3B', 'DDX27', 'KPNA2']",type 1 diabetes mellitus,endothelial cell,KPNA2,"Among the genes LINC02361, EVA1C, SMPDL3B, DDX27, and KPNA2, which one exhibits the highest endothelial cell-specific expression and is therefore the most promising candidate for targeted interventions in type 1 diabetes mellitus?","Among the genes LINC02361, EVA1C, SMPDL3B, DDX27, and KPNA2, which one exhibits the highest endothelial cell-specific expression and is therefore the most promising candidate for targeted interventions in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the endothelial cell-activated genes identified in PINNACLE, representing the cell-type–specific targets for type 1 diabetes mellitus. Calculate the average embedding for this overlapping set as a reference, then compute the cosine similarity between this reference and each individual target embedding. If one gene shows a substantially higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['SPINK5', 'LINC01492', 'HSPB1', 'PTEN', 'DNTTIP2']",type 1 diabetes mellitus,unknown,PTEN,"Which gene among SPINK5, LINC01492, HSPB1, PTEN, and DNTTIP2 exhibits the most pronounced cell-type-specific expression relevant to targeting type 1 diabetes mellitus?","Which gene among SPINK5, LINC01492, HSPB1, PTEN, and DNTTIP2 exhibits the most pronounced cell-type-specific expression relevant to targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which unknown-activated genes in PINNACLE overlap with these targets to define cell-type–specific targets for the disease. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between each individual target’s embedding and this reference. Identify the gene with a markedly higher similarity than the rest as the top candidate, and provide a concise, evidence-based rationale for its biological relevance."
"['NID2', 'IGFBP7', 'ITLN2', 'SLC11A2', 'AGPAT4']",type 1 diabetes mellitus,unknown,IGFBP7,"Among the genes NID2, IGFBP7, ITLN2, SLC11A2, and AGPAT4, which one shows the highest degree of cell-type-specific expression and is the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Among the genes NID2, IGFBP7, ITLN2, SLC11A2, and AGPAT4, which one shows the highest degree of cell-type-specific expression and is the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the genes activated in PINNACLE that are otherwise uncharacterized. Calculate the average embedding for this overlapping set and then compute the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity relative to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FUT8', 'MT1F', 'COBL', 'CSTF3', 'LAMA1']",type 1 diabetes mellitus,unknown,COBL,"Which gene among FUT8, MT1F, COBL, CSTF3, and LAMA1 exhibits the highest cell-type specificity relevant for targeting type 1 diabetes mellitus?","Which gene among FUT8, MT1F, COBL, CSTF3, and LAMA1 exhibits the highest cell-type specificity relevant for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Then, determine which unknown activated genes in PINNACLE overlap with these targets to define cell-type–specific targets for the disease. Compute the average embedding of this set, and calculate the cosine similarity between this average and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['MAP3K2-DT', 'SOX4', 'GPRACR', 'SNRPN', 'FAM219A']",type 1 diabetes mellitus,unknown,SOX4,"Which gene among MAP3K2-DT, SOX4, GPRACR, SNRPN, and FAM219A exhibits the highest cell-type specificity, thereby representing the most promising candidate target for type 1 diabetes mellitus?","Which gene among MAP3K2-DT, SOX4, GPRACR, SNRPN, and FAM219A exhibits the highest cell-type specificity, thereby representing the most promising candidate target for type 1 diabetes mellitus? Using the PINNACLE dataset, identify verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings. Next, determine which unknown-activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific candidate genes. Compute the average embedding for these candidates, then calculate the cosine similarity between this reference and each individual candidate’s embedding. If one gene exhibits a markedly higher similarity score than the others, nominate it as the primary candidate and provide a concise, evidence-based rationale for its biological significance."
"['CTXND1', 'NUP93-DT', 'DIRAS2', 'TTC39C-AS1', 'B4GALT3']",type 1 diabetes mellitus,unknown,DIRAS2,"Among the genes CTXND1, NUP93-DT, DIRAS2, TTC39C-AS1, and B4GALT3, which exhibits the highest degree of cell-type-specific expression, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Among the genes CTXND1, NUP93-DT, DIRAS2, TTC39C-AS1, and B4GALT3, which exhibits the highest degree of cell-type-specific expression, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the confirmed therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, assess which genes among the unknown-activated set in PINNACLE overlap with these targets to define cell-type–specific targets for the disease. Compute the average embedding for this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene shows substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MYO10', 'TMTC2', 'UBL3', 'LINC00324', 'MT-ND5']",type 1 diabetes mellitus,unknown,MT-ND5,"Which gene among MYO10, TMTC2, UBL3, LINC00324, and MT-ND5 exhibits the highest cell-type specificity and may represent the most promising candidate target for type 1 diabetes mellitus?","Which gene among MYO10, TMTC2, UBL3, LINC00324, and MT-ND5 exhibits the highest cell-type specificity and may represent the most promising candidate target for type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Then, determine which unknown-activated genes in PINNACLE overlap with these targets to establish a set of cell-type–specific therapeutic targets. Compute the average embedding of this set and calculate the cosine similarity between this reference and each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['INS', 'PSD2', 'LINC01352', 'CIART', 'GIHCG']",type 1 diabetes mellitus,unknown,INS,"Which gene among INS, PSD2, LINC01352, CIART, and GIHCG demonstrates the highest degree of cell-type specificity, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among INS, PSD2, LINC01352, CIART, and GIHCG demonstrates the highest degree of cell-type specificity, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which genes activated in PINNACLE overlap with these targets to define the cell-type–specific target set for type 1 diabetes. Calculate the average embedding for this set and compute the cosine similarity between this average and each individual gene embedding. If one gene exhibits a notably higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based explanation for its biological significance."
"['LAMTOR5', 'DGKH', 'SPINK4', 'SPIRE1', 'UBE2N']",type 1 diabetes mellitus,unknown,SPIRE1,"Which gene among LAMTOR5, DGKH, SPINK4, SPIRE1, and UBE2N exhibits the most pronounced cell-type-specific expression in tissues relevant to type 1 diabetes mellitus?","Which gene among LAMTOR5, DGKH, SPINK4, SPIRE1, and UBE2N exhibits the most pronounced cell-type-specific expression in tissues relevant to type 1 diabetes mellitus? Identify verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type-specific embeddings from PINNACLE. Next, determine which unknown activated genes in PINNACLE overlap with these targets to delineate a set of cell-type-specific therapeutic targets. Compute the average embedding of these targets and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['LINC02447', 'KCNK2', 'SP110', 'TNIK', 'UBLCP1']",type 1 diabetes mellitus,unknown,UBLCP1,"Which gene among LINC02447, KCNK2, SP110, TNIK, and UBLCP1 exhibits the highest cell-type specificity for targeting type 1 diabetes mellitus?","Which gene among LINC02447, KCNK2, SP110, TNIK, and UBLCP1 exhibits the highest cell-type specificity for targeting type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE dataset. Determine which unknown-activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific candidates. Calculate the average embedding of this overlapping set as a reference and then compute the cosine similarity between this reference and each individual target gene. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['KLHL36', 'EMC1-AS1', 'GJB2', 'CLEC2B', 'CLEC3A']",type 1 diabetes mellitus,unknown,CLEC2B,"Among the candidate genes KLHL36, EMC1-AS1, GJB2, CLEC2B, and CLEC3A, which exhibits the highest cell-type specificity, making it the most promising target for type 1 diabetes mellitus?","Among the candidate genes KLHL36, EMC1-AS1, GJB2, CLEC2B, and CLEC3A, which exhibits the highest cell-type specificity, making it the most promising target for type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific gene embeddings from the PINNACLE database. Next, determine which genes with unknown activation status in PINNACLE overlap with these targets to define the cell-type–specific target set. Compute the average embedding for this set as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits notably higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale highlighting its biological relevance."
"['NDUFAB1', 'THSD4', 'NUP93', 'ADCY9', 'H3-3A']",type 1 diabetes mellitus,unknown,NDUFAB1,"Which gene among NDUFAB1, THSD4, NUP93, ADCY9, and H3-3A exhibits the highest cell-type specificity and represents the most promising candidate for therapeutic targeting in type 1 diabetes mellitus?","Which gene among NDUFAB1, THSD4, NUP93, ADCY9, and H3-3A exhibits the highest cell-type specificity and represents the most promising candidate for therapeutic targeting in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which unknown-activated genes from PINNACLE overlap with these targets, thereby defining a set of cell-type–specific candidate genes. Compute the average embedding for this candidate set and then calculate the cosine similarity between this average and each individual gene’s embedding. If one gene displays a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance in type 1 diabetes mellitus."
"['M6PR', 'SLF2', 'ZNF474', 'PBXIP1', 'LINC01345']",type 1 diabetes mellitus,unknown,M6PR,"Which gene among M6PR, SLF2, ZNF474, PBXIP1, and LINC01345 shows the highest cell-type specificity in cell populations associated with type 1 diabetes mellitus?","Which gene among M6PR, SLF2, ZNF474, PBXIP1, and LINC01345 shows the highest cell-type specificity in cell populations associated with type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of the unknown-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for type 1 diabetes. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['HERC5', 'ATP10B', 'KRTAP5-1', 'TEKT5', 'PITPNA']",type 1 diabetes mellitus,unknown,ATP10B,"Among the genes HERC5, ATP10B, KRTAP5-1, TEKT5, and PITPNA, which one exhibits the highest cell-type specificity, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Among the genes HERC5, ATP10B, KRTAP5-1, TEKT5, and PITPNA, which one exhibits the highest cell-type specificity, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Using PINNACLE, first identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings. Next, determine which unknown-activated genes overlap with these targets in PINNACLE, and compute the average embedding of this overlapping set as a reference. Calculate the cosine similarity between this reference and each individual target’s embedding, and then nominate the gene with a markedly higher similarity than the others as the top candidate. Provide a concise, evidence-based rationale for its biological relevance."
"['HIPK1', 'C2CD2', 'TMEM37', 'TRMT2B', 'MGAT5']",type 1 diabetes mellitus,unknown,HIPK1,"Which gene among HIPK1, C2CD2, TMEM37, TRMT2B, and MGAT5 exhibits the highest cell-type specificity relevant for therapeutic targeting in type 1 diabetes mellitus?","Which gene among HIPK1, C2CD2, TMEM37, TRMT2B, and MGAT5 exhibits the highest cell-type specificity relevant for therapeutic targeting in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type-specific embeddings from PINNACLE. Next, determine which unknown-activated genes in PINNACLE overlap with these targets, thereby defining a set of cell-type-specific targets for type 1 diabetes mellitus. Compute the average embedding for this set and calculate the cosine similarity between this average and the embedding of each individual gene. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GBP2', 'ANP32A', 'GMFG', 'RALBP1', 'FOXN3']",type 1 diabetes mellitus,unknown,FOXN3,"Among GBP2, ANP32A, GMFG, RALBP1, and FOXN3, which gene demonstrates the highest cell-type-specific expression relevant to therapeutic targeting in type 1 diabetes mellitus?","Among GBP2, ANP32A, GMFG, RALBP1, and FOXN3, which gene demonstrates the highest cell-type-specific expression relevant to therapeutic targeting in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Then, determine the overlap between these targets and the unknown-activated genes in PINNACLE to create a set of cell-type–specific candidates. Compute the average embedding for this set and calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['ACYP2', 'CYB5A', 'SPRR2B', 'CLIC1', 'ATP13A5-AS1']",type 1 diabetes mellitus,unknown,CLIC1,"Among the genes ACYP2, CYB5A, SPRR2B, CLIC1, and ATP13A5-AS1, which one shows the highest cell-type specificity and warrants further investigation as a potential target in type 1 diabetes mellitus?","Among the genes ACYP2, CYB5A, SPRR2B, CLIC1, and ATP13A5-AS1, which one shows the highest cell-type specificity and warrants further investigation as a potential target in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which unknown-activated genes in PINNACLE overlap with these targets, and calculate the average embedding for this overlapping group. Then, compute the cosine similarity between this average embedding and each individual target embedding. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PF4V1', 'SRRM2-AS1', 'MT-ND6', 'HPR', 'NUP205']",type 1 diabetes mellitus,unknown,MT-ND6,"Among the genes PF4V1, SRRM2-AS1, MT-ND6, HPR, and NUP205, which one exhibits the highest cell-type specificity in the context of type 1 diabetes mellitus, making it the best candidate for targeted intervention?","Among the genes PF4V1, SRRM2-AS1, MT-ND6, HPR, and NUP205, which one exhibits the highest cell-type specificity in the context of type 1 diabetes mellitus, making it the best candidate for targeted intervention? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which targets overlap with the unknown-activated genes in PINNACLE to define a set of cell-type–specific targets. Compute the average embedding for this set and calculate the cosine similarity between the average and each individual target. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['GLIS2-AS1', 'ATAD3C', 'YIPF6', 'UCHL3', 'TIMM9']",type 1 diabetes mellitus,unknown,UCHL3,"Which gene among GLIS2-AS1, ATAD3C, YIPF6, UCHL3, and TIMM9 demonstrates the most pronounced cell-type-specific expression relevant to type 1 diabetes mellitus targeting?","Which gene among GLIS2-AS1, ATAD3C, YIPF6, UCHL3, and TIMM9 demonstrates the most pronounced cell-type-specific expression relevant to type 1 diabetes mellitus targeting? Determine the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Identify which unknown-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for type 1 diabetes. Then, compute the average embedding of this overlapping set as a reference and calculate the cosine similarity between the reference and each target's embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['TRAK1', 'LINC01344', 'NDUFA3', 'RAP1B', 'CDIPT']",type 1 diabetes mellitus,unknown,NDUFA3,"Among the genes TRAK1, LINC01344, NDUFA3, RAP1B, and CDIPT, which one displays the most pronounced cell-type-specific expression profile relevant to targeted interventions for type 1 diabetes mellitus?","Among the genes TRAK1, LINC01344, NDUFA3, RAP1B, and CDIPT, which one displays the most pronounced cell-type-specific expression profile relevant to targeted interventions for type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the activated genes not previously characterized in PINNACLE to define the cell-type–specific targets for type 1 diabetes. Compute the average embedding of this overlap set, then calculate the cosine similarity between this average and the embedding of each individual target. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['LRRC3B', 'PAX2', 'MIR34AHG', 'MSANTD1', 'PDGFRB']",type 1 diabetes mellitus,unknown,PDGFRB,"Which gene among LRRC3B, PAX2, MIR34AHG, MSANTD1, and PDGFRB exhibits the highest cell-type specificity as a candidate target for type 1 diabetes mellitus?","Which gene among LRRC3B, PAX2, MIR34AHG, MSANTD1, and PDGFRB exhibits the highest cell-type specificity as a candidate target for type 1 diabetes mellitus? Identify all experimentally validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which of the unknown-activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific targets. Calculate the average embedding of this set as a reference, then compute the cosine similarity of each individual target to this reference. If one gene exhibits a substantially higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based explanation of its biological relevance."
"['LINC00970', 'POT1-AS1', 'SCGN', 'POMK', 'PTK7']",type 1 diabetes mellitus,pancreatic a cell,SCGN,"Which gene among LINC00970, POT1-AS1, SCGN, POMK, and PTK7 exhibits the greatest specificity in pancreatic α cells, making it the optimal candidate for targeting in type 1 diabetes mellitus research?","Which gene among LINC00970, POT1-AS1, SCGN, POMK, and PTK7 exhibits the greatest specificity in pancreatic α cells, making it the optimal candidate for targeting in type 1 diabetes mellitus research? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE database. Next, identify the pancreatic α cell–activated genes that intersect with these targets. For this overlapping set, compute the average embedding and then determine the cosine similarity between this average and each individual target’s embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['C4orf48', 'CYBRD1', 'FOLR1', 'ACSM2B', 'MTCH1']",type 1 diabetes mellitus,pancreatic a cell,MTCH1,"Which gene among C4orf48, CYBRD1, FOLR1, ACSM2B, and MTCH1 exhibits the highest cell-type specificity in pancreatic alpha cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among C4orf48, CYBRD1, FOLR1, ACSM2B, and MTCH1 exhibits the highest cell-type specificity in pancreatic alpha cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which targets overlap with the pancreatic α cell–activated genes in PINNACLE. Compute the average embedding of this overlapping set as a reference and then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FSIP1', 'ZNF841', 'CCDC127', 'HBP1', 'ACP1']",type 1 diabetes mellitus,pancreatic a cell,HBP1,"Which gene among FSIP1, ZNF841, CCDC127, HBP1, and ACP1 exhibits the highest specificity for pancreatic alpha cells, thereby serving as the most promising target for type 1 diabetes mellitus intervention?","Which gene among FSIP1, ZNF841, CCDC127, HBP1, and ACP1 exhibits the highest specificity for pancreatic alpha cells, thereby serving as the most promising target for type 1 diabetes mellitus intervention? Identify the verified therapeutic targets of type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which pancreatic α cell-activated genes in PINNACLE overlap with these targets, defining a cell-type–specific set of targets. Compute the average embedding of this set and calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['C1orf105', 'C6orf136', 'SNX8', 'PCDHB8', 'EXPH5']",type 1 diabetes mellitus,pancreatic a cell,C6orf136,"Among the candidate genes C1orf105, C6orf136, SNX8, PCDHB8, and EXPH5, which one exhibits the highest expression specificity in pancreatic alpha cells, making it a promising target for type 1 diabetes mellitus intervention?","Among the candidate genes C1orf105, C6orf136, SNX8, PCDHB8, and EXPH5, which one exhibits the highest expression specificity in pancreatic alpha cells, making it a promising target for type 1 diabetes mellitus intervention? Identify all verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with genes activated in pancreatic α cells, thereby defining a subset of cell-type–specific targets. Compute the average embedding for this subset and then calculate the cosine similarity between this reference and the embedding of each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['GARRE1', 'GP2', 'SCAMP2', 'RAB11FIP3', 'OPTN']",type 1 diabetes mellitus,pancreatic a cell,GP2,"Among the genes GARRE1, GP2, SCAMP2, RAB11FIP3, and OPTN, which exhibits the highest cell-type specificity in pancreatic alpha cells for targeting type 1 diabetes mellitus?","Among the genes GARRE1, GP2, SCAMP2, RAB11FIP3, and OPTN, which exhibits the highest cell-type specificity in pancreatic alpha cells for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Then, determine the overlap between these targets and the genes activated in pancreatic alpha cells in PINNACLE. For this overlapping set, compute the average embedding as a reference profile and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['NPIPA1', 'DPPA5', 'IFIT3', 'ATXN7L3B', 'DHRS4L2']",type 1 diabetes mellitus,pancreatic a cell,ATXN7L3B,"Among NPIPA1, DPPA5, IFIT3, ATXN7L3B, and DHRS4L2, which gene exhibits the highest cell-type specificity in pancreatic alpha cells for targeted intervention in type 1 diabetes mellitus?","Among NPIPA1, DPPA5, IFIT3, ATXN7L3B, and DHRS4L2, which gene exhibits the highest cell-type specificity in pancreatic alpha cells for targeted intervention in type 1 diabetes mellitus? Using the PINNACLE database, identify validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings. Next, determine which of these targets overlap with pancreatic alpha cell-activated genes from PINNACLE. Compute the average embedding for the overlapping targets to serve as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PAH', 'ANXA5', 'CDK17', 'PRSS12', 'SEC61G']",type 1 diabetes mellitus,pancreatic a cell,ANXA5,"Among the genes PAH, ANXA5, CDK17, PRSS12, and SEC61G, which one exhibits the highest specificity within pancreatic alpha cells for targeting type 1 diabetes mellitus?","Among the genes PAH, ANXA5, CDK17, PRSS12, and SEC61G, which one exhibits the highest specificity within pancreatic alpha cells for targeting type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of the pancreatic alpha-cell–activated genes in PINNACLE overlap with these targets to define a cell-type–specific target set. Compute the average embedding of these overlapping genes and calculate the cosine similarity between this reference and each individual target. If one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MRPL40', 'ZNF843', 'GCFC2', 'ARHGEF7-AS2', 'MT-ND3']",type 1 diabetes mellitus,pancreatic a cell,MT-ND3,"Which gene among MRPL40, ZNF843, GCFC2, ARHGEF7-AS2, and MT‐ND3 exhibits the highest specificity for pancreatic alpha cells, making it the prime candidate for targeting type 1 diabetes mellitus?","Which gene among MRPL40, ZNF843, GCFC2, ARHGEF7-AS2, and MT‐ND3 exhibits the highest specificity for pancreatic alpha cells, making it the prime candidate for targeting type 1 diabetes mellitus? Using the verified therapeutic targets for type 1 diabetes mellitus, extract their cell-type–specific embeddings from the PINNACLE database. Identify the overlap between these targets and the genes activated in pancreatic alpha cells to define the cell-type–specific targets for type 1 diabetes. Then, compute the average embedding of this set and calculate the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based justification for its biological relevance."
"['PCED1B', 'HMX2', 'ASB1', 'PM20D2', 'SLC5A1']",type 1 diabetes mellitus,pancreatic a cell,SLC5A1,"Which gene among PCED1B, HMX2, ASB1, PM20D2, and SLC5A1 exhibits the highest specificity for pancreatic beta cells, making it the most promising target for type 1 diabetes mellitus interventions?","Which gene among PCED1B, HMX2, ASB1, PM20D2, and SLC5A1 exhibits the highest specificity for pancreatic beta cells, making it the most promising target for type 1 diabetes mellitus interventions? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type specific embeddings from the PINNACLE dataset. Next, determine which genes activated in pancreatic alpha cells overlap with these targets; this overlapping set represents the cell-type specific therapeutic candidates. Calculate the average embedding for these candidates as a reference, then compute the cosine similarity between this reference and each individual gene embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological significance."
"['DNASE1L1', 'C2-AS1', 'KPNA7', 'EMSY', 'ESCO2']",type 1 diabetes mellitus,pancreatic a cell,EMSY,"Which gene among DNASE1L1, C2-AS1, KPNA7, EMSY, and ESCO2 exhibits the highest specificity for pancreatic alpha cells, thereby emerging as the most promising target for type 1 diabetes mellitus intervention?","Which gene among DNASE1L1, C2-AS1, KPNA7, EMSY, and ESCO2 exhibits the highest specificity for pancreatic alpha cells, thereby emerging as the most promising target for type 1 diabetes mellitus intervention? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of the pancreatic alpha cell–activated genes in PINNACLE overlap with these targets. Using this overlapping set as the cell-specific targets, compute the average embedding and then calculate the cosine similarity between this reference and each individual target gene. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SHH', 'ATF6B', 'OCEL1', 'ZNHIT2', 'MIAT']",type 1 diabetes mellitus,pancreatic a cell,ATF6B,"Among the genes SHH, ATF6B, OCEL1, ZNHIT2, and MIAT, which demonstrates the highest cell-type specificity in pancreatic alpha cells as a potential target for type 1 diabetes mellitus therapy?","Among the genes SHH, ATF6B, OCEL1, ZNHIT2, and MIAT, which demonstrates the highest cell-type specificity in pancreatic alpha cells as a potential target for type 1 diabetes mellitus therapy? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the pancreatic alpha cell-activated genes in PINNACLE to define cell-type–specific targets for T1D. Compute the average embedding for these overlapping genes and calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RNF216', 'UNC93B1', 'C16orf87', 'FADD', 'GOLGA8M_ENSG00000261480']",type 1 diabetes mellitus,pancreatic a cell,RNF216,"Which gene among RNF216, UNC93B1, C16orf87, FADD, and GOLGA8M (ENSG00000261480) demonstrates the highest cell-type specificity in pancreatic alpha cells, making it the most promising single candidate for targeted therapy in type 1 diabetes mellitus?","Which gene among RNF216, UNC93B1, C16orf87, FADD, and GOLGA8M (ENSG00000261480) demonstrates the highest cell-type specificity in pancreatic alpha cells, making it the most promising single candidate for targeted therapy in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which pancreatic alpha cell-activated genes overlap with these targets. Compute the average embedding of this overlapping set, then calculate the cosine similarity between this reference embedding and each individual target. If one gene clearly exhibits a higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based explanation for its biological relevance."
"['RAB26', 'SETD2', 'GPR141', 'PLA2G4A', 'BLTP1']",type 1 diabetes mellitus,pancreatic a cell,BLTP1,"Which gene among RAB26, SETD2, GPR141, PLA2G4A, and BLTP1 exhibits the highest specificity for pancreatic alpha cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among RAB26, SETD2, GPR141, PLA2G4A, and BLTP1 exhibits the highest specificity for pancreatic alpha cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify experimentally validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type-specific embeddings from the PINNACLE dataset. Next, identify the subset of these targets that overlap with pancreatic α-cell–activated genes in PINNACLE to define cell-type-specific targets for type 1 diabetes. Compute the average embedding for these overlapping genes as a reference, then calculate the cosine similarity between this reference and each individual target's embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance to type 1 diabetes."
"['KLF5', 'TMEM167A', 'KANSL1', 'SSB', 'FRY']",type 1 diabetes mellitus,pancreatic a cell,KANSL1,"Among the genes KLF5, TMEM167A, KANSL1, SSB, and FRY, which one shows the most specific expression in pancreatic alpha cells, making it the most promising target for type 1 diabetes mellitus intervention?","Among the genes KLF5, TMEM167A, KANSL1, SSB, and FRY, which one shows the most specific expression in pancreatic alpha cells, making it the most promising target for type 1 diabetes mellitus intervention? Identify and extract the cell-type-specific embeddings for verified therapeutic targets of type 1 diabetes mellitus from PINNACLE. Next, determine which pancreatic alpha cell-activated genes intersect with these targets, and compute their average embedding as a reference. Then, calculate the cosine similarity between this reference and each individual overlapping gene embedding. Finally, if one gene shows a distinctly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological significance."
"['OPN3', 'ZDHHC11', 'ZBTB20-AS5', 'DPP4', 'AIFM2']",type 1 diabetes mellitus,pancreatic a cell,DPP4,"Among OPN3, ZDHHC11, ZBTB20-AS5, DPP4, and AIFM2, which gene exhibits the highest specificity for pancreatic α cells, making it the best candidate for targeted interventions in type 1 diabetes mellitus?","Among OPN3, ZDHHC11, ZBTB20-AS5, DPP4, and AIFM2, which gene exhibits the highest specificity for pancreatic α cells, making it the best candidate for targeted interventions in type 1 diabetes mellitus? Which verified therapeutic targets for type 1 diabetes mellitus have corresponding cell‐type–specific embeddings in PINNACLE? Identify the overlap between these targets and the pancreatic alpha cell–activated genes in PINNACLE, designate this overlapping set as the cell-type–specific targets for type 1 diabetes, and compute their average embedding. Next, calculate the cosine similarity between this average and the individual gene embeddings. If one gene exhibits a markedly higher similarity compared to the others, designate it as the top candidate and provide a concise, evidence-supported rationale for its biological relevance."
"['AGK-DT', 'INS', 'CMIP', 'MAP1A', 'LINC01374']",type 1 diabetes mellitus,pancreatic a cell,INS,"Among the genes AGK-DT, INS, CMIP, MAP1A, and LINC01374, which one exhibits the highest cell-type specificity in pancreatic alpha cells for potential targeting in type 1 diabetes mellitus?","Among the genes AGK-DT, INS, CMIP, MAP1A, and LINC01374, which one exhibits the highest cell-type specificity in pancreatic alpha cells for potential targeting in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with PINNACLE's pancreatic α cell-activated genes to form the set of cell-type–specific targets. Compute the average embedding of this target set and calculate the cosine similarity between this average and each individual target. If one gene displays a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['VEZT', 'SND1', 'TTC12', 'GPATCH3', 'HSPA5']",type 1 diabetes mellitus,pancreatic a cell,SND1,"Among VEZT, SND1, TTC12, GPATCH3, and HSPA5, which gene exhibits the highest cell-type specificity in pancreatic α cells, thereby representing the most promising target for therapeutic intervention in type 1 diabetes mellitus?","Among VEZT, SND1, TTC12, GPATCH3, and HSPA5, which gene exhibits the highest cell-type specificity in pancreatic α cells, thereby representing the most promising target for therapeutic intervention in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type-specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with genes activated in pancreatic alpha‐cells, thereby defining a set of cell-type-specific targets for type 1 diabetes. Compute the average embedding of this overlapping set and calculate the cosine similarity between each individual target’s embedding and the average vector. If one gene displays a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FBXO42', 'MARK2', 'ASAP1', 'MAB21L2', 'MYSM1']",type 1 diabetes mellitus,pancreatic a cell,ASAP1,"Which gene—FBXO42, MARK2, ASAP1, MAB21L2, or MYSM1—exhibits the highest cell-type specificity in pancreatic alpha cells for potential targeted therapy in type 1 diabetes mellitus?","Which gene—FBXO42, MARK2, ASAP1, MAB21L2, or MYSM1—exhibits the highest cell-type specificity in pancreatic alpha cells for potential targeted therapy in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the genes activated in pancreatic α cells; this overlapping set represents the cell-type–specific targets. Compute the average embedding of these overlapping targets, and then calculate the cosine similarity between this average embedding and the embedding of each individual target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate, and provide a concise evidence-based rationale for its biological relevance."
"['C22orf31', 'LINC01780', 'MRPL19', 'HECTD4', 'ZNF391']",type 1 diabetes mellitus,pancreatic a cell,HECTD4,"Which gene—C22orf31, LINC01780, MRPL19, HECTD4, or ZNF391—displays the highest cell-type specificity in pancreatic alpha cells, making it the most promising target for type 1 diabetes mellitus intervention?","Which gene—C22orf31, LINC01780, MRPL19, HECTD4, or ZNF391—displays the highest cell-type specificity in pancreatic alpha cells, making it the most promising target for type 1 diabetes mellitus intervention? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of the pancreatic alpha cell–activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets. Compute the average embedding of these overlapping targets and calculate the cosine similarity between this average and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['PYY', 'FAM66B', 'GGN', 'CNOT8', 'SLC44A4']",type 1 diabetes mellitus,pancreatic a cell,SLC44A4,"Which gene among PYY, FAM66B, GGN, CNOT8, and SLC44A4 exhibits the highest cell-type specificity in pancreatic α cells in the context of type 1 diabetes mellitus?","Which gene among PYY, FAM66B, GGN, CNOT8, and SLC44A4 exhibits the highest cell-type specificity in pancreatic α cells in the context of type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus within PINNACLE and retrieve their cell-type–specific embeddings. Determine the overlap between these targets and the genes activated in pancreatic alpha cells. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and the embedding of each individual target gene. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['KIF9', 'NDUFB1', 'TRMU', 'PTPN21', 'SDK2']",type 1 diabetes mellitus,pancreatic stellate cell,NDUFB1,"Which gene among KIF9, NDUFB1, TRMU, PTPN21, and SDK2 shows the most specific expression in pancreatic stellate cells for potential targeted interventions in type 1 diabetes mellitus?","Which gene among KIF9, NDUFB1, TRMU, PTPN21, and SDK2 shows the most specific expression in pancreatic stellate cells for potential targeted interventions in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with the pancreatic stellate cell-activated genes in PINNACLE to define the cell-type–specific targets. Calculate the average embedding of this overlapping set, and then compute the cosine similarity between the average embedding and each individual target's embedding. If one gene consistently exhibits a higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZNF875', 'TAL2', 'INSR', 'PDLIM5', 'TNK2-AS1']",type 1 diabetes mellitus,pancreatic stellate cell,INSR,"Which gene—ZNF875, TAL2, INSR, PDLIM5, or TNK2-AS1—exhibits the highest cell-type specificity in pancreatic stellate cells for targeting type 1 diabetes mellitus?","Which gene—ZNF875, TAL2, INSR, PDLIM5, or TNK2-AS1—exhibits the highest cell-type specificity in pancreatic stellate cells for targeting type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus (T1DM) and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which pancreatic stellate cell–activated genes, also present in PINNACLE, overlap with these targets to define a set of cell-type–specific T1DM targets. Compute the average embedding for these overlapping genes, then calculate the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MT-ND4', 'RELL2', 'HNF4A', 'REPIN1', 'ROS1']",type 1 diabetes mellitus,pancreatic stellate cell,MT-ND4,"Among the candidate genes MT-ND4, RELL2, HNF4A, REPIN1, and ROS1, which exhibits the highest cell-type specificity in pancreatic stellate cells for targeting type 1 diabetes mellitus?","Among the candidate genes MT-ND4, RELL2, HNF4A, REPIN1, and ROS1, which exhibits the highest cell-type specificity in pancreatic stellate cells for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE database. Then, determine the overlap between these targets and the pancreatic stellate cell–activated genes in PINNACLE to define the cell-type–specific targets for type 1 diabetes. Calculate the average embedding for this overlapping set and determine the cosine similarity between this reference and each individual target. If one gene displays a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CTSB', 'FGF11', 'IFT122', 'DCHS2', 'NDUFB10']",type 1 diabetes mellitus,pancreatic stellate cell,NDUFB10,"Which gene among CTSB, FGF11, IFT122, DCHS2, and NDUFB10 exhibits the highest cell-type specificity in pancreatic stellate cells in the context of targeting type 1 diabetes mellitus?","Which gene among CTSB, FGF11, IFT122, DCHS2, and NDUFB10 exhibits the highest cell-type specificity in pancreatic stellate cells in the context of targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which genes activated in pancreatic stellate cells overlap with these targets. For the overlapping gene set, compute the average embedding and then calculate the cosine similarity between this reference and each individual embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DUOX2', 'SLC1A5', 'HBD', 'YTHDF1', 'GPR84']",type 1 diabetes mellitus,pancreatic stellate cell,SLC1A5,"Which gene among DUOX2, SLC1A5, HBD, YTHDF1, and GPR84 demonstrates the highest cell-type specificity in pancreatic stellate cells for targeting type 1 diabetes mellitus?","Which gene among DUOX2, SLC1A5, HBD, YTHDF1, and GPR84 demonstrates the highest cell-type specificity in pancreatic stellate cells for targeting type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the pancreatic stellate cell–activated genes in PINNACLE. Compute the average embedding of the overlapping set to serve as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate, and provide a concise, evidence-based rationale for its biological relevance."
"['NUP188', 'UNC5B', 'MT-ND3', 'LAPTM4A-DT', 'STAT3']",type 1 diabetes mellitus,pancreatic stellate cell,MT-ND3,"Among the genes NUP188, UNC5B, MT-ND3, LAPTM4A-DT, and STAT3, which exhibits the highest specificity in pancreatic stellate cells for therapeutic targeting in type 1 diabetes mellitus?","Among the genes NUP188, UNC5B, MT-ND3, LAPTM4A-DT, and STAT3, which exhibits the highest specificity in pancreatic stellate cells for therapeutic targeting in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the pancreatic stellate cell-activated genes documented in PINNACLE. For the overlapping set, compute the average embedding to serve as a reference and calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based explanation for its biological relevance."
"['LEMD1-DT', 'PHKA2-AS1', 'PTRHD1', 'FAM83A-AS1', 'ZNF611']",type 1 diabetes mellitus,pancreatic stellate cell,PTRHD1,"Which gene among LEMD1-DT, PHKA2-AS1, PTRHD1, FAM83A-AS1, and ZNF611 exhibits the highest cell-type specific expression in pancreatic stellate cells as a potential target for type 1 diabetes mellitus?","Which gene among LEMD1-DT, PHKA2-AS1, PTRHD1, FAM83A-AS1, and ZNF611 exhibits the highest cell-type specific expression in pancreatic stellate cells as a potential target for type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with pancreatic stellate cell–activated genes in PINNACLE, and compute the average embedding for this overlapping set. Then, calculate the cosine similarity between this average embedding and that of each individual target. If one gene exhibits a significantly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['THAP9', 'NDUFS6', 'ACP5', 'LGMN', 'LINC01611']",type 1 diabetes mellitus,pancreatic stellate cell,NDUFS6,"Which gene among THAP9, NDUFS6, ACP5, LGMN, and LINC01611 exhibits the highest specificity for pancreatic stellate cells, making it the most suitable candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among THAP9, NDUFS6, ACP5, LGMN, and LINC01611 exhibits the highest specificity for pancreatic stellate cells, making it the most suitable candidate for targeted intervention in type 1 diabetes mellitus? Using verified therapeutic targets for type 1 diabetes mellitus, retrieve their cell-type–specific embeddings from PINNACLE. Identify which genes activated in pancreatic stellate cells overlap with these targets. Next, compute the average embedding of the overlapping genes and determine the cosine similarity between this average and each individual gene's embedding. If a single gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LINC02324', 'AP4S1', 'IQCB1', 'KCNJ8', 'SGK3']",type 1 diabetes mellitus,pancreatic stellate cell,KCNJ8,"Which gene—LINC02324, AP4S1, IQCB1, KCNJ8, or SGK3—demonstrates the highest cell-type specificity in pancreatic stellate cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Which gene—LINC02324, AP4S1, IQCB1, KCNJ8, or SGK3—demonstrates the highest cell-type specificity in pancreatic stellate cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with genes activated in pancreatic stellate cells within PINNACLE, as this overlapping set represents the cell-type–specific targets for the disease. Calculate the average embedding for these overlapping targets, and compute the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance in type 1 diabetes mellitus."
"['IL1R1', 'ZNF519', 'UPRT', 'STK17B', 'KCNH5']",type 1 diabetes mellitus,pancreatic stellate cell,IL1R1,"Which gene among IL1R1, ZNF519, UPRT, STK17B, and KCNH5 exhibits the highest cell-type specificity in pancreatic stellate cells for targeted intervention in type 1 diabetes mellitus?","Which gene among IL1R1, ZNF519, UPRT, STK17B, and KCNH5 exhibits the highest cell-type specificity in pancreatic stellate cells for targeted intervention in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of the genes activated in pancreatic stellate cells overlap with these targets to define cell-type–specific targets for type 1 diabetes. Compute the average embedding of this overlapping set and calculate the cosine similarity between this reference and each individual embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['HECTD3', 'GPR180', 'CYTL1', 'LINC00678', 'CTRB1']",type 1 diabetes mellitus,pancreatic stellate cell,CTRB1,"Among the genes HECTD3, GPR180, CYTL1, LINC00678, and CTRB1, which one exhibits the highest cell-type specificity in pancreatic stellate cells for targeting type 1 diabetes mellitus?","Among the genes HECTD3, GPR180, CYTL1, LINC00678, and CTRB1, which one exhibits the highest cell-type specificity in pancreatic stellate cells for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of the pancreatic stellate cell–activated genes from PINNACLE overlap with these targets, defining your cell-type–specific target set. Calculate the average embedding of this overlap set to serve as a reference, then compute the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['NEDD1', 'NF1', 'ZNF350-AS1', 'CACHD1', 'TAPBP']",type 1 diabetes mellitus,pancreatic stellate cell,TAPBP,"Which gene among NEDD1, NF1, ZNF350-AS1, CACHD1, and TAPBP exhibits the highest specificity for pancreatic stellate cells as a potential target for type 1 diabetes mellitus?","Which gene among NEDD1, NF1, ZNF350-AS1, CACHD1, and TAPBP exhibits the highest specificity for pancreatic stellate cells as a potential target for type 1 diabetes mellitus? Identify verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which pancreatic stellate cell-activated genes in PINNACLE overlap with these targets to establish a set of cell-type–specific targets for type 1 diabetes. Calculate the average embedding of this set as a reference, then compute the cosine similarity between this reference and each individual target embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PLEK2', 'ASAP1', 'HNRNPA0', 'ANXA10', 'IGSF21']",type 1 diabetes mellitus,pancreatic stellate cell,ASAP1,"Among the genes PLEK2, ASAP1, HNRNPA0, ANXA10, and IGSF21, which shows the highest cell-type specificity in pancreatic stellate cells and thus represents the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Among the genes PLEK2, ASAP1, HNRNPA0, ANXA10, and IGSF21, which shows the highest cell-type specificity in pancreatic stellate cells and thus represents the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the pancreatic stellate cell-activated genes in PINNACLE. Using this overlapping set as the cell-type–specific targets, compute their average embedding as a reference and then calculate the cosine similarity between this reference and each individual target's embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PSG4', 'TEP1', 'INS', 'PLAC8', 'MMP16']",type 1 diabetes mellitus,pancreatic stellate cell,INS,"Which gene among PSG4, TEP1, INS, PLAC8, and MMP16 exhibits the highest cell-type specificity in pancreatic stellate cells as a potential target for type 1 diabetes mellitus?","Which gene among PSG4, TEP1, INS, PLAC8, and MMP16 exhibits the highest cell-type specificity in pancreatic stellate cells as a potential target for type 1 diabetes mellitus? Which verified therapeutic targets for type 1 diabetes mellitus have cell-type–specific embeddings in PINNACLE, and which of these overlap with the pancreatic stellate cell activation gene set? Compute the average embedding of these overlapping targets as a reference, then calculate the cosine similarity between each target’s embedding and this reference. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['IMPDH2', 'GRID2IP', 'ZNF677', 'COMMD4', 'CARD18']",type 1 diabetes mellitus,pancreatic stellate cell,IMPDH2,"Among IMPDH2, GRID2IP, ZNF677, COMMD4, and CARD18, which gene exhibits the highest cell-type specificity in pancreatic stellate cells, making it the most suitable candidate for targeting type 1 diabetes mellitus?","Among IMPDH2, GRID2IP, ZNF677, COMMD4, and CARD18, which gene exhibits the highest cell-type specificity in pancreatic stellate cells, making it the most suitable candidate for targeting type 1 diabetes mellitus? Identify the experimentally validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the genes activated in pancreatic stellate cells as defined in PINNACLE, and compute the average embedding for this intersecting set. Finally, calculate the cosine similarity between this average embedding and that of each individual target, and if one gene exhibits a significantly higher similarity, nominate it as the primary candidate—with a succinct, evidence-based justification for its biological significance."
"['RELL2', 'LINC01767', 'EBF1', 'MYO18B', 'ARFGAP3']",type 1 diabetes mellitus,pancreatic stellate cell,EBF1,"Among the following genes—RELL2, LINC01767, EBF1, MYO18B, ARFGAP3—which one exhibits the highest cell-type-specific expression in pancreatic stellate cells, positioning it as the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Among the following genes—RELL2, LINC01767, EBF1, MYO18B, ARFGAP3—which one exhibits the highest cell-type-specific expression in pancreatic stellate cells, positioning it as the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine the overlap between these targets and the genes activated in pancreatic stellate cells, thereby defining the cell-type–specific targets relevant to the disease. Compute the average embedding of this overlapping set as a reference, and then calculate the cosine similarity between this reference embedding and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['SND1', 'RORA-AS1', 'VPS18', 'LRRC66', 'GFRA3']",type 1 diabetes mellitus,pancreatic stellate cell,SND1,"Which gene among SND1, RORA-AS1, VPS18, LRRC66, and GFRA3 exhibits the highest cell-type specificity in pancreatic stellate cells and represents the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among SND1, RORA-AS1, VPS18, LRRC66, and GFRA3 exhibits the highest cell-type specificity in pancreatic stellate cells and represents the most promising candidate for targeting type 1 diabetes mellitus? Determine the validated therapeutic targets for type 1 diabetes and retrieve their cell-type–specific embeddings from PINNACLE. Identify the overlap between these targets and the pancreatic stellate cell–activated genes in PINNACLE, which will represent the cell-type–specific targets for type 1 diabetes. Next, compute the average embedding for this overlapping set as a reference, and calculate the cosine similarity between this reference and each individual target. Finally, if one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ATP13A1', 'MIR3663HG', 'PRND', 'MT-ND5', 'PCDH12']",type 1 diabetes mellitus,pancreatic stellate cell,MT-ND5,"Among the genes ATP13A1, MIR3663HG, PRND, MT-ND5, and PCDH12, which exhibits the highest cell-type-specific expression in pancreatic stellate cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Among the genes ATP13A1, MIR3663HG, PRND, MT-ND5, and PCDH12, which exhibits the highest cell-type-specific expression in pancreatic stellate cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Determine the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Identify the overlap between these targets and the pancreatic stellate cell–activated genes in PINNACLE, defining these overlapping genes as cell-type–specific targets. Compute the average embedding of this subset, then calculate the cosine similarity between this reference and each individual target's embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['PTGS1', 'PHYHD1', 'IFITM2', 'SCARNA9', 'LINC01208']",type 1 diabetes mellitus,pancreatic stellate cell,PTGS1,"Among PTGS1, PHYHD1, IFITM2, SCARNA9, and LINC01208, which gene exhibits the highest specificity for pancreatic stellate cells, making it the most promising candidate for therapeutic intervention in type 1 diabetes mellitus?","Among PTGS1, PHYHD1, IFITM2, SCARNA9, and LINC01208, which gene exhibits the highest specificity for pancreatic stellate cells, making it the most promising candidate for therapeutic intervention in type 1 diabetes mellitus? Using the PINNACLE dataset, identify the confirmed therapeutic targets for type 1 diabetes mellitus along with their cell-type-specific embeddings. Next, determine the overlap between these targets and the genes activated in pancreatic stellate cells, defining this intersection as the cell-type-specific targets. Calculate the average embedding of this gene set and then compute the cosine similarity between this average and each individual target’s embedding. If one gene demonstrates significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['KANK4', 'RERE-AS1', 'NDUFA13', 'VSIG10', 'NTSR2']",type 1 diabetes mellitus,pancreatic stellate cell,NDUFA13,"Among the following genes—KANK4, RERE-AS1, NDUFA13, VSIG10, and NTSR2—which one exhibits the most specific expression in pancreatic stellate cells, making it a promising target for intervention in type 1 diabetes mellitus?","Among the following genes—KANK4, RERE-AS1, NDUFA13, VSIG10, and NTSR2—which one exhibits the most specific expression in pancreatic stellate cells, making it a promising target for intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Determine which of the genes activated in pancreatic stellate cells in PINNACLE coincide with these targets. Compute the average embedding for the overlapping set and calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CUL9', 'IPO4', 'GEMIN6', 'CMTM7', 'ZNF652']",type 1 diabetes mellitus,pancreatic acinar cell,ZNF652,"Which gene among CUL9, IPO4, GEMIN6, CMTM7, and ZNF652 demonstrates the highest cell-type specificity in pancreatic acinar cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among CUL9, IPO4, GEMIN6, CMTM7, and ZNF652 demonstrates the highest cell-type specificity in pancreatic acinar cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the pancreatic acinar cell–activated genes in PINNACLE. For the overlapping set, compute the average embedding as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FFAR4', 'SGF29', 'WARS2-IT1', 'RGCC', 'STBD1']",type 1 diabetes mellitus,pancreatic acinar cell,SGF29,"Which gene among FFAR4, SGF29, WARS2-IT1, RGCC, and STBD1 exhibits the highest expression specificity in pancreatic acinar cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among FFAR4, SGF29, WARS2-IT1, RGCC, and STBD1 exhibits the highest expression specificity in pancreatic acinar cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes and retrieve their corresponding cell-type-specific embeddings from PINNACLE. Next, determine the overlap between these targets and the pancreatic acinar cell-activated genes in PINNACLE to define the cell-type-specific targets for type 1 diabetes. Compute the average embedding for this overlapping set and then calculate the cosine similarity between this reference and each individual target. If one gene demonstrates a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MAP2', 'STARD9', 'SMIM19', 'GATD3', 'MOSPD1']",type 1 diabetes mellitus,pancreatic acinar cell,GATD3,"Among the genes MAP2, STARD9, SMIM19, GATD3, and MOSPD1, which one exhibits the highest cell-type specificity in pancreatic acinar cells as a potential target for type 1 diabetes mellitus?","Among the genes MAP2, STARD9, SMIM19, GATD3, and MOSPD1, which one exhibits the highest cell-type specificity in pancreatic acinar cells as a potential target for type 1 diabetes mellitus? Using the PINNACLE database, retrieve the cell-type–specific embeddings for verified therapeutic targets of type 1 diabetes mellitus. Next, identify the overlap between these targets and pancreatic acinar cell–activated genes in PINNACLE. Compute the average embedding for the overlapping gene set, then calculate the cosine similarity between this reference embedding and each target’s embedding. If a single gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FST', 'H3-3A', 'NDUFS3', 'FAM53A', 'TSFM']",type 1 diabetes mellitus,pancreatic acinar cell,NDUFS3,"Which gene among FST, H3-3A, NDUFS3, FAM53A, and TSFM exhibits the highest cell-type specificity in pancreatic acinar cells for targeting type 1 diabetes mellitus?","Which gene among FST, H3-3A, NDUFS3, FAM53A, and TSFM exhibits the highest cell-type specificity in pancreatic acinar cells for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets associated with type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the set of pancreatic acinar cell–activated genes in PINNACLE to establish the disease-relevant, cell-type–specific targets. Compute the average embedding of this overlapping set and calculate the cosine similarity between this average and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['TRGC1', 'STRA8', 'R3HCC1L', 'TRIM7-AS1', 'COBL']",type 1 diabetes mellitus,pancreatic acinar cell,COBL,"Which gene among TRGC1, STRA8, R3HCC1L, TRIM7‐AS1, and COBL exhibits the highest specificity in pancreatic acinar cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among TRGC1, STRA8, R3HCC1L, TRIM7‐AS1, and COBL exhibits the highest specificity in pancreatic acinar cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type specific embeddings from the PINNACLE dataset. Then, determine which pancreatic acinar cell-activated genes from PINNACLE overlap with these targets, forming the cell-type specific targets for the disease. Calculate the average embedding for these overlapping genes as a reference, and compute the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FBXW9', 'TBC1D8', 'NDUFC1', 'LIPC-AS1', 'TAF5L']",type 1 diabetes mellitus,pancreatic acinar cell,NDUFC1,"Among FBXW9, TBC1D8, NDUFC1, LIPC-AS1, and TAF5L, which gene exhibits the highest specificity in pancreatic acinar cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Among FBXW9, TBC1D8, NDUFC1, LIPC-AS1, and TAF5L, which gene exhibits the highest specificity in pancreatic acinar cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type-specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with genes activated in pancreatic acinar cells. For the overlapping set, compute the average embedding vector and assess the cosine similarity between this reference vector and each individual target’s embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['KCNK16', 'PGAP3', 'OR10K1', 'LINC02172', 'VWA8']",type 1 diabetes mellitus,pancreatic acinar cell,PGAP3,"Which gene among KCNK16, PGAP3, OR10K1, LINC02172, and VWA8 exhibits the highest specificity for pancreatic acinar cells, thereby representing the most promising target for type 1 diabetes mellitus research?","Which gene among KCNK16, PGAP3, OR10K1, LINC02172, and VWA8 exhibits the highest specificity for pancreatic acinar cells, thereby representing the most promising target for type 1 diabetes mellitus research? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type-specific embeddings from the PINNACLE database. Next, determine which targets overlap with the pancreatic acinar cell-activated genes in PINNACLE, and compute the average embedding of this overlapping set as a reference. Then, calculate the cosine similarity between this reference and each individual target's embedding. If a single gene shows a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['EIF3C', 'KCTD6', 'CHODL', 'YTHDF3-DT', 'SLC8A1-AS1']",type 1 diabetes mellitus,pancreatic acinar cell,EIF3C,"Which gene among EIF3C, KCTD6, CHODL, YTHDF3-DT, and SLC8A1-AS1 exhibits the highest specificity of expression in pancreatic acinar cells, thereby making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among EIF3C, KCTD6, CHODL, YTHDF3-DT, and SLC8A1-AS1 exhibits the highest specificity of expression in pancreatic acinar cells, thereby making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine the pancreatic acinar cell–activated genes in PINNACLE that overlap with these targets. Compute the average embedding of this overlapping set, then calculate the cosine similarity between this average and each individual gene’s embedding. If one gene displays markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['H2AC15', 'ZNF678', 'SCRN1', 'TLE3', 'SPRYD3']",type 1 diabetes mellitus,pancreatic acinar cell,SPRYD3,"Which gene among H2AC15, ZNF678, SCRN1, TLE3, and SPRYD3 exhibits the highest cell-type-specific expression in pancreatic acinar cells, making it the most suitable candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among H2AC15, ZNF678, SCRN1, TLE3, and SPRYD3 exhibits the highest cell-type-specific expression in pancreatic acinar cells, making it the most suitable candidate for targeted intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with genes activated in pancreatic acinar cells in PINNACLE, thereby establishing the cell-type–specific targets for type 1 diabetes mellitus. Compute the average embedding of this overlapping set to serve as a reference vector, and then calculate the cosine similarity between this reference and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['ERICH6', 'BCL2L15', 'SORBS2', 'PPM1F-AS1', 'HMGCL']",type 1 diabetes mellitus,pancreatic acinar cell,BCL2L15,"Which gene among ERICH6, BCL2L15, SORBS2, PPM1F-AS1, and HMGCL shows the highest specificity for pancreatic acinar cells, making it the most promising single candidate target for type 1 diabetes mellitus?","Which gene among ERICH6, BCL2L15, SORBS2, PPM1F-AS1, and HMGCL shows the highest specificity for pancreatic acinar cells, making it the most promising single candidate target for type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which targets overlap with the set of pancreatic acinar cell–activated genes in PINNACLE to define the cell-type–specific targets for type 1 diabetes mellitus. Compute the average embedding for this overlapping set and calculate the cosine similarity between the average embedding and each individual target. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SLC16A4', 'LINC01991', 'CYLD-AS1', 'SLC2A4', 'RSPH3']",type 1 diabetes mellitus,pancreatic acinar cell,RSPH3,"Among the genes SLC16A4, LINC01991, CYLD-AS1, SLC2A4, and RSPH3, which one exhibits the highest cell-type specificity in pancreatic acinar cells relevant to type 1 diabetes mellitus?","Among the genes SLC16A4, LINC01991, CYLD-AS1, SLC2A4, and RSPH3, which one exhibits the highest cell-type specificity in pancreatic acinar cells relevant to type 1 diabetes mellitus? Identify all verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with pancreatic acinar cell-activated genes in PINNACLE. For the overlapping set, compute the average embedding to serve as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RAF1', 'PPFIA2', 'ZNF25', 'RLIM', 'SCGB1B2P']",type 1 diabetes mellitus,pancreatic acinar cell,RAF1,"Among the candidate genes RAF1, PPFIA2, ZNF25, RLIM, and SCGB1B2P, which demonstrates the highest specificity for pancreatic acinar cells, making it the most promising target for type 1 diabetes mellitus?","Among the candidate genes RAF1, PPFIA2, ZNF25, RLIM, and SCGB1B2P, which demonstrates the highest specificity for pancreatic acinar cells, making it the most promising target for type 1 diabetes mellitus? Using current literature-defined therapeutic targets for type 1 diabetes mellitus, retrieve their cell-type–specific gene embeddings from the PINNACLE dataset. Identify the genes that overlap with pancreatic acinar cell-activated genes in PINNACLE to define the cell-type–specific targets. Next, compute the average embedding for this overlapping set and calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['CCNO', 'NVL', 'SPIRE1', 'FKBP1B', 'FBXO46']",type 1 diabetes mellitus,pancreatic acinar cell,SPIRE1,"Which gene among CCNO, NVL, SPIRE1, FKBP1B, and FBXO46 exhibits the highest cell-type specificity in pancreatic acinar cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among CCNO, NVL, SPIRE1, FKBP1B, and FBXO46 exhibits the highest cell-type specificity in pancreatic acinar cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Determine the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type specific embeddings from PINNACLE. Next, identify which of these targets overlap with genes activated in pancreatic acinar cells, defining this intersection as the cell-type specific targets for type 1 diabetes. Compute the average embedding of this overlapping set as a reference, and calculate the cosine similarity between this reference and each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['NDUFS5', 'KIAA2012-AS1', 'RBM15', 'NMT2', 'C1QTNF9']",type 1 diabetes mellitus,pancreatic acinar cell,NDUFS5,"Among the genes NDUFS5, KIAA2012-AS1, RBM15, NMT2, and C1QTNF9, which one exhibits the highest cell-type specificity in pancreatic acinar cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Among the genes NDUFS5, KIAA2012-AS1, RBM15, NMT2, and C1QTNF9, which one exhibits the highest cell-type specificity in pancreatic acinar cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Determine the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Identify the overlap between these targets and the pancreatic acinar cell-activated genes in PINNACLE to define the cell-specific targets for type 1 diabetes mellitus. Compute the average embedding of this overlapping set, then calculate the cosine similarity for each individual target against this average. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LIN54', 'SUOX', 'RELL2', 'BBS9', 'MTHFD2']",type 1 diabetes mellitus,pancreatic acinar cell,SUOX,"Which gene among LIN54, SUOX, RELL2, BBS9, and MTHFD2 exhibits the highest cell-type specificity in pancreatic acinar cells for potential therapeutic targeting of type 1 diabetes mellitus?","Which gene among LIN54, SUOX, RELL2, BBS9, and MTHFD2 exhibits the highest cell-type specificity in pancreatic acinar cells for potential therapeutic targeting of type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the genes activated in pancreatic acinar cells from the same dataset. Using this overlapping set, calculate the average embedding as a reference, and compute the cosine similarity between this reference and each individual target. If a single gene shows a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['RASAL2-AS1', 'DMWD', 'FKRP', 'MOCS2', 'TRIM17']",type 1 diabetes mellitus,pancreatic acinar cell,FKRP,"Which gene among RASAL2-AS1, DMWD, FKRP, MOCS2, and TRIM17 exhibits the highest cell-type specificity in pancreatic acinar cells for targeting type 1 diabetes mellitus?","Which gene among RASAL2-AS1, DMWD, FKRP, MOCS2, and TRIM17 exhibits the highest cell-type specificity in pancreatic acinar cells for targeting type 1 diabetes mellitus? Which verified therapeutic targets of type 1 diabetes mellitus exhibit cell‐type–specific expression in PINNACLE? Specifically, among the pancreatic acinar cell–activated genes recorded in PINNACLE, which ones overlap with these therapeutic targets? Once identified, compute the average embedding for this overlapping set as a reference, and then calculate the cosine similarity between each individual gene’s embedding and the reference embedding. If one gene shows a substantially higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence‐based rationale for its biological relevance."
"['SLC20A2', 'SDCBP2-AS1', 'DYNLT1', 'LEMD2', 'ALG5']",type 1 diabetes mellitus,pancreatic acinar cell,LEMD2,"Which gene among SLC20A2, SDCBP2-AS1, DYNLT1, LEMD2, and ALG5 exhibits the highest specificity for pancreatic acinar cells, making it the most promising candidate for targeted interventions in type 1 diabetes mellitus?","Which gene among SLC20A2, SDCBP2-AS1, DYNLT1, LEMD2, and ALG5 exhibits the highest specificity for pancreatic acinar cells, making it the most promising candidate for targeted interventions in type 1 diabetes mellitus? Determine the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Identify the subset of pancreatic acinar cell-activated genes that overlap with these targets, designating them as the cell-type–specific targets for type 1 diabetes mellitus. Next, compute the average embedding for this subset to serve as a reference, and calculate the cosine similarity between this reference and each individual target gene. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ARHGEF6', 'ETV3', 'CRHR2', 'TEX26-AS1', 'NDUFB6']",type 1 diabetes mellitus,pancreatic acinar cell,NDUFB6,"Among ARHGEF6, ETV3, CRHR2, TEX26-AS1, and NDUFB6, which gene demonstrates the highest specificity in pancreatic acinar cells, making it the most promising target for therapeutic strategies in type 1 diabetes mellitus?","Among ARHGEF6, ETV3, CRHR2, TEX26-AS1, and NDUFB6, which gene demonstrates the highest specificity in pancreatic acinar cells, making it the most promising target for therapeutic strategies in type 1 diabetes mellitus? Using the set of verified therapeutic targets for type 1 diabetes mellitus, obtain their cell-type–specific embeddings from PINNACLE. Next, identify which of the pancreatic acinar cell-activated genes in PINNACLE overlap with these targets. For the overlapping genes, calculate the average embedding to serve as a reference and then compute the cosine similarity between this reference and each gene's individual embedding. Determine if one gene exhibits a significantly higher similarity score compared to the others, and if so, nominate it as the top candidate. Provide a concise, evidence-based rationale for its biological relevance in type 1 diabetes mellitus."
"['LINC02730', 'C3orf20', 'LINC01435', 'ORMDL3', 'TMEM223']",type 1 diabetes mellitus,pancreatic acinar cell,ORMDL3,"Which gene among LINC02730, C3orf20, LINC01435, ORMDL3, and TMEM223 exhibits the highest cell-type-specific expression in pancreatic acinar cells, making it the optimal candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among LINC02730, C3orf20, LINC01435, ORMDL3, and TMEM223 exhibits the highest cell-type-specific expression in pancreatic acinar cells, making it the optimal candidate for targeted intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE database. Then, determine the overlap between these targets and the pancreatic acinar cell–activated genes in PINNACLE to define the cell-type–specific therapeutic set. Calculate the average embedding of this overlapping set and compute the cosine similarity between this reference embedding and each individual gene embedding. Finally, if one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['PCMTD2', 'LYST', 'CTBP1', 'SPATA1', 'TATDN3']",type 1 diabetes mellitus,pancreatic acinar cell,TATDN3,"Among the genes PCMTD2, LYST, CTBP1, SPATA1, and TATDN3, which one exhibits the highest cell-type specific expression in pancreatic acinar cells relevant to type 1 diabetes mellitus?","Among the genes PCMTD2, LYST, CTBP1, SPATA1, and TATDN3, which one exhibits the highest cell-type specific expression in pancreatic acinar cells relevant to type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, from the set of pancreatic acinar cell-activated genes in PINNACLE, determine the overlap with these targets to define the cell-type–specific targets for type 1 diabetes mellitus. Compute the average embedding of this overlapping set and then calculate the cosine similarity between this reference embedding and the embedding of each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CTRB1', 'SPATA4', 'CCDC198', 'TRMT9B', 'METRNL']",type 1 diabetes mellitus,pp cell,CTRB1,"Among the genes CTRB1, SPATA4, CCDC198, TRMT9B, and METRNL, which one exhibits the highest cell-type specificity in pp cells for targeting type 1 diabetes mellitus?","Among the genes CTRB1, SPATA4, CCDC198, TRMT9B, and METRNL, which one exhibits the highest cell-type specificity in pp cells for targeting type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these genes overlap with the pp cell-activated genes in PINNACLE to define the cell-type–specific targets. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between the reference and each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFA9', 'IRX2', 'FAM78B', 'GBP4', 'PCDHB6']",type 1 diabetes mellitus,pp cell,NDUFA9,"Which gene—NDUFA9, IRX2, FAM78B, GBP4, or PCDHB6—exhibits the highest cell-type specificity in pp cells for targeting type 1 diabetes mellitus?","Which gene—NDUFA9, IRX2, FAM78B, GBP4, or PCDHB6—exhibits the highest cell-type specificity in pp cells for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their corresponding cell-type–specific embeddings from PINNACLE. Next, compare these with the pp cell-activated genes in PINNACLE to determine which targets overlap, thereby defining the cell-type–specific targets for the disease. Calculate the average embedding of this overlapping set and use it as a reference to compute the cosine similarity with each overlapping target. If one gene demonstrates a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ALG2', 'C1orf122', 'SLC22A31', 'NUP54', 'MAP1LC3B2']",type 1 diabetes mellitus,pp cell,C1orf122,"Among the genes ALG2, C1orf122, SLC22A31, NUP54, and MAP1LC3B2, which one exhibits the highest cell-type specificity in pancreatic cells for targeting type 1 diabetes mellitus?","Among the genes ALG2, C1orf122, SLC22A31, NUP54, and MAP1LC3B2, which one exhibits the highest cell-type specificity in pancreatic cells for targeting type 1 diabetes mellitus? Identify verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Then, determine which cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets. Compute the average embedding of this overlapping set and calculate the cosine similarity between this average embedding and the embedding of each individual target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate, and provide a concise, evidence-based rationale for its biological relevance."
"['COX5B', 'SPICE1', 'RBPJ', 'CLDN4', 'LINC02872']",type 1 diabetes mellitus,pp cell,RBPJ,"Among the genes COX5B, SPICE1, RBPJ, CLDN4, and LINC02872, which one shows the highest cell-type specificity in pp cells for targeting type 1 diabetes mellitus?","Among the genes COX5B, SPICE1, RBPJ, CLDN4, and LINC02872, which one shows the highest cell-type specificity in pp cells for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from the PINNACLE database. Then, determine which genes in the PINNACLE cell-type activated set overlap with these targets to define a subset of cell-type–specific targets for type 1 diabetes mellitus. Compute the average embedding for this overlapping set, and calculate the cosine similarity between the average embedding and each individual target’s embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['HECTD4', 'MYBPC3', 'STT3B', 'KIRREL2', 'BRIP1']",type 1 diabetes mellitus,pp cell,HECTD4,"Among HECTD4, MYBPC3, STT3B, KIRREL2, and BRIP1, which gene exhibits the highest cell-type specificity in pancreatic progenitor cells, thereby representing the most promising target for type 1 diabetes mellitus interventions?","Among HECTD4, MYBPC3, STT3B, KIRREL2, and BRIP1, which gene exhibits the highest cell-type specificity in pancreatic progenitor cells, thereby representing the most promising target for type 1 diabetes mellitus interventions? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Determine which of these targets overlap with the pp cell-activated genes in PINNACLE, thereby defining a cell-type–specific candidate set for type 1 diabetes. Compute the average embedding of this set as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LINC01641', 'MAPK1', 'CNTF', 'TBC1D8', 'LINC01415']",type 1 diabetes mellitus,pp cell,MAPK1,"Which gene among LINC01641, MAPK1, CNTF, TBC1D8, and LINC01415 exhibits the highest cell-type specificity in pp cells for targeting type 1 diabetes mellitus?","Which gene among LINC01641, MAPK1, CNTF, TBC1D8, and LINC01415 exhibits the highest cell-type specificity in pp cells for targeting type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Determine which of the pp cell–activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific targets for type 1 diabetes mellitus. Compute the average embedding of this overlapping set to serve as a reference, then calculate the cosine similarity between this reference embedding and each individual target’s embedding. If one gene exhibits a significantly higher cosine similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CCDC90B', 'HMGN4', 'AKAP7', 'BRAF', 'THORLNC']",type 1 diabetes mellitus,pp cell,BRAF,"Which gene among CCDC90B, HMGN4, AKAP7, BRAF, and THORLNC exhibits the highest cell-type specificity in pp cells as a candidate target for type 1 diabetes mellitus?","Which gene among CCDC90B, HMGN4, AKAP7, BRAF, and THORLNC exhibits the highest cell-type specificity in pp cells as a candidate target for type 1 diabetes mellitus? Identify the therapeutically validated targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which targets overlap with the set of pp cell-activated genes in PINNACLE; this overlapping group comprises your cell-type–specific candidate targets. Calculate the average embedding for these candidates, then measure the cosine similarity between this average and each individual candidate embedding. If one gene exhibits a substantially higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['B3GALNT1', 'HIPK1', 'MVP', 'SNRPD2', 'LRRC8D-DT']",type 1 diabetes mellitus,pp cell,HIPK1,"Which gene among B3GALNT1, HIPK1, MVP, SNRPD2, and LRRC8D-DT exhibits the highest cell-type specificity in pancreatic progenitor cells for targeting type 1 diabetes mellitus?","Which gene among B3GALNT1, HIPK1, MVP, SNRPD2, and LRRC8D-DT exhibits the highest cell-type specificity in pancreatic progenitor cells for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the PP cell-activated gene set from PINNACLE to define the cell-type–specific targets. Calculate the average embedding of this intersecting set to establish a reference profile, and then compute the cosine similarity between this reference and each individual target's embedding. If one gene displays markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['IL6ST', 'SLC13A5', 'NISCH', 'TRAM1L1', 'EIF2B5-DT']",type 1 diabetes mellitus,pp cell,IL6ST,"Among the genes IL6ST, SLC13A5, NISCH, TRAM1L1, and EIF2B5-DT, which one exhibits the highest cell-type specificity in pp cells as a potential therapeutic target for type 1 diabetes mellitus?","Among the genes IL6ST, SLC13A5, NISCH, TRAM1L1, and EIF2B5-DT, which one exhibits the highest cell-type specificity in pp cells as a potential therapeutic target for type 1 diabetes mellitus? Identify all validated therapeutic targets for type 1 diabetes mellitus and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which pancreatic cell-activated genes overlap with these targets to define a set of cell-type–specific targets. Calculate the average embedding for this set as a reference, then compute the cosine similarity between each target’s embedding and the reference. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['LINC01714', 'IFITM5', 'KDM5A', 'SEPTIN2', 'IK']",type 1 diabetes mellitus,pp cell,SEPTIN2,"Among the genes LINC01714, IFITM5, KDM5A, SEPTIN2, and IK, which one exhibits the highest cell-type specificity in pp cells relevant to targeting type 1 diabetes mellitus?","Among the genes LINC01714, IFITM5, KDM5A, SEPTIN2, and IK, which one exhibits the highest cell-type specificity in pp cells relevant to targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus that have cell-type–specific embeddings in PINNACLE. Next, determine which of the pp cell-activated genes overlap with these targets to define a set of cell-type–specific targets. Compute the average embedding of these overlapping genes as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFA13', 'CKAP4', 'TANGO2', 'OSR1', 'ABRAXAS2']",type 1 diabetes mellitus,pp cell,NDUFA13,"Which gene among NDUFA13, CKAP4, TANGO2, OSR1, and ABRAXAS2 exhibits the highest cell-type specificity in pp cells relevant to targeting type 1 diabetes mellitus?","Which gene among NDUFA13, CKAP4, TANGO2, OSR1, and ABRAXAS2 exhibits the highest cell-type specificity in pp cells relevant to targeting type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type-specific embeddings from the PINNACLE dataset. Next, determine which pp cell-activated genes in PINNACLE overlap with these targets to form a set of cell-type-specific T1D targets. Calculate the average embedding of this set as a reference, and then compute the cosine similarity between this reference and the embedding of each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale supporting its biological relevance."
"['IARS2', 'DIXDC1', 'KDM2A', 'GALNT7', 'MT-ND3']",type 1 diabetes mellitus,pp cell,MT-ND3,"Among the following genes—IARS2, DIXDC1, KDM2A, GALNT7, and MT-ND3—which exhibits the highest cell-type specificity in pancreatic progenitor cells relevant to targeting type 1 diabetes mellitus?","Among the following genes—IARS2, DIXDC1, KDM2A, GALNT7, and MT-ND3—which exhibits the highest cell-type specificity in pancreatic progenitor cells relevant to targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell type–specific embeddings from PINNACLE. Next, determine which of the pp cell‐activated genes in PINNACLE intersect with these targets to form the set of cell type–specific therapeutic candidates. Calculate the average embedding of this candidate set and then compute the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate that gene as the top candidate and provide a concise, evidence‐based rationale for its biological relevance to type 1 diabetes mellitus."
"['NDUFS1', 'PLEKHN1', 'FAM81A', 'DLX6-AS1', 'KCNJ6']",type 1 diabetes mellitus,pp cell,NDUFS1,"Which gene among NDUFS1, PLEKHN1, FAM81A, DLX6-AS1, and KCNJ6 exhibits the highest cell-type specificity in PP cells, thereby representing the most promising target for type 1 diabetes mellitus interventions?","Which gene among NDUFS1, PLEKHN1, FAM81A, DLX6-AS1, and KCNJ6 exhibits the highest cell-type specificity in PP cells, thereby representing the most promising target for type 1 diabetes mellitus interventions? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which pp cell–activated genes overlap with these targets to define the cell-type–specific targets for the disease. Calculate the average embedding of this overlapping set as a reference, then compute the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LINC00954', 'SLC25A5', 'JAK1', 'LINC01742', 'SEMA3G']",type 1 diabetes mellitus,pp cell,JAK1,"Which gene among LINC00954, SLC25A5, JAK1, LINC01742, and SEMA3G exhibits the highest cell-type specificity in pancreatic progenitor cells for potential therapeutic targeting of type 1 diabetes mellitus?","Which gene among LINC00954, SLC25A5, JAK1, LINC01742, and SEMA3G exhibits the highest cell-type specificity in pancreatic progenitor cells for potential therapeutic targeting of type 1 diabetes mellitus? Identify all verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Then, determine which of these targets overlap with the pp cell-activated genes in PINNACLE to define a set of cell-type–specific targets. Compute the average embedding of this overlapping set, and calculate the cosine similarity between this average and each target’s individual embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ENSA', 'PNMA3', 'RBM17', 'RNU6ATAC35P', 'ZSCAN20']",type 1 diabetes mellitus,pp cell,RBM17,"Which gene among ENSA, PNMA3, RBM17, RNU6ATAC35P, and ZSCAN20 exhibits the highest cell-type specificity in pp cells, thereby representing the best candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among ENSA, PNMA3, RBM17, RNU6ATAC35P, and ZSCAN20 exhibits the highest cell-type specificity in pp cells, thereby representing the best candidate for targeted intervention in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, assess which pp cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for type 1 diabetes. Calculate the average embedding of this overlapping set and then compute the cosine similarity between this mean embedding and the embedding of each individual target. If one gene shows substantially higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its potential biological relevance in type 1 diabetes."
"['FICD', 'TAFA3', 'PLA2G12A', 'LYRM4', 'IL6R']",type 1 diabetes mellitus,pp cell,IL6R,"Among the genes FICD, TAFA3, PLA2G12A, LYRM4, and IL6R, which one shows the highest cell‐type–specific expression in PP cells relevant to type 1 diabetes mellitus targeting?","Among the genes FICD, TAFA3, PLA2G12A, LYRM4, and IL6R, which one shows the highest cell‐type–specific expression in PP cells relevant to type 1 diabetes mellitus targeting? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which pp cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific target set. Compute the average embedding across these overlapping genes, then calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['FAM72C', 'ALDH2', 'ESRRB', 'NSF', 'NAGPA']",type 1 diabetes mellitus,pp cell,ALDH2,"Which gene among FAM72C, ALDH2, ESRRB, NSF, and NAGPA exhibits the highest cell-type specificity in pancreatic progenitor cells, making it the most promising target for therapeutic intervention in type 1 diabetes mellitus?","Which gene among FAM72C, ALDH2, ESRRB, NSF, and NAGPA exhibits the highest cell-type specificity in pancreatic progenitor cells, making it the most promising target for therapeutic intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which pancreatic cell-activation genes in PINNACLE overlap with these targets. For the overlapping set, compute the average embedding as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the primary candidate, providing a concise, evidence-based rationale for its biological relevance."
"['ZKSCAN2-DT', 'PDLIM4', 'GFPT1', 'LRRC28', 'TRIB3']",type 1 diabetes mellitus,pp cell,PDLIM4,"Which gene among 'ZKSCAN2-DT', 'PDLIM4', 'GFPT1', 'LRRC28', and 'TRIB3' displays the highest cell-type-specific expression in pp cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among 'ZKSCAN2-DT', 'PDLIM4', 'GFPT1', 'LRRC28', and 'TRIB3' displays the highest cell-type-specific expression in pp cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Then, determine which targets overlap with the pp cell-activated gene set in PINNACLE, defining a subset of cell-type–specific targets. Compute the average embedding for this subset and calculate the cosine similarity between this average and each individual target embedding. If one gene shows substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PPP1R14B', 'SPIB', 'NOTCH1', 'MAGEA10', 'FHIT']",type 1 diabetes mellitus,pp cell,PPP1R14B,"Among the genes PPP1R14B, SPIB, NOTCH1, MAGEA10, and FHIT, which one exhibits the highest cell-type specificity in pp cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Among the genes PPP1R14B, SPIB, NOTCH1, MAGEA10, and FHIT, which one exhibits the highest cell-type specificity in pp cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type-specific embeddings from PINNACLE. Next, determine which of these targets overlap with the pp cell-activated genes. For this overlapping set, compute the average embedding as a reference and calculate the cosine similarity between this reference and each individual target embedding. If one gene consistently exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['METTL15', 'NDUFA3', 'OR5H14', 'LINC01954', 'DOCK8']",type 1 diabetes mellitus,pp cell,NDUFA3,"Which gene among METTL15, NDUFA3, OR5H14, LINC01954, and DOCK8 exhibits the highest cell-type specificity in pp cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among METTL15, NDUFA3, OR5H14, LINC01954, and DOCK8 exhibits the highest cell-type specificity in pp cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type-specific embeddings from the PINNACLE database. Next, determine the overlap between the pp cell-activated genes in PINNACLE and these targets, which defines the cell-type-specific targets for type 1 diabetes. Calculate the average embedding of this overlapping set to use as a reference and compute the cosine similarity between this reference and each individual target embedding. If one gene demonstrates a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SULT1B1', 'TOMM40', 'OPRD1', 'BMT2', 'MLEC']",type 1 diabetes mellitus,type b pancreatic cell,OPRD1,"Among the genes SULT1B1, TOMM40, OPRD1, BMT2, and MLEC, which one demonstrates the highest cell-type specificity in pancreatic beta cells, making it the most suitable candidate for targeted intervention in type 1 diabetes mellitus?","Among the genes SULT1B1, TOMM40, OPRD1, BMT2, and MLEC, which one demonstrates the highest cell-type specificity in pancreatic beta cells, making it the most suitable candidate for targeted intervention in type 1 diabetes mellitus? Identify the confirmed therapeutic targets for type 1 diabetes and extract their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the type b pancreatic cell–activated genes from PINNACLE. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target embedding. Finally, if one gene exhibits a significantly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FAN1', 'C20orf173', 'EFNB1', 'ALDH2', 'MARCHF10']",type 1 diabetes mellitus,type b pancreatic cell,ALDH2,"Which gene among FAN1, C20orf173, EFNB1, ALDH2, and MARCHF10 exhibits the highest cell-type specificity in pancreatic type B cells as a potential target for treating type 1 diabetes mellitus?","Which gene among FAN1, C20orf173, EFNB1, ALDH2, and MARCHF10 exhibits the highest cell-type specificity in pancreatic type B cells as a potential target for treating type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of the type b pancreatic cell-activated genes in PINNACLE overlap with these targets to create a set of cell-type–specific candidates. Compute the average embedding for this set, then calculate the cosine similarity between this reference and each individual target gene. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TP53BP1', 'SLC12A2', 'H1-10', 'NDUFS8', 'DACT2']",type 1 diabetes mellitus,type b pancreatic cell,NDUFS8,"Which gene among TP53BP1, SLC12A2, H1-10, NDUFS8, and DACT2 exhibits the highest cell-type specificity in pancreatic beta cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among TP53BP1, SLC12A2, H1-10, NDUFS8, and DACT2 exhibits the highest cell-type specificity in pancreatic beta cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their corresponding cell-type-specific embeddings from PINNACLE. Next, determine which of these targets overlap with the genes activated in type b pancreatic cells as recorded in PINNACLE. Compute the average embedding of these overlapping targets and evaluate the cosine similarity between this reference embedding and each individual target's embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate, and provide a concise, evidence-based explanation for its potential biological relevance."
"['ARHGAP29', 'EPB41L5', 'ITGB3BP', 'TBC1D25', 'FBXW7']",type 1 diabetes mellitus,type b pancreatic cell,ITGB3BP,"Among the genes ARHGAP29, EPB41L5, ITGB3BP, TBC1D25, and FBXW7, which one exhibits the highest cell-type specificity in pancreatic beta cells with potential relevance to type 1 diabetes mellitus?","Among the genes ARHGAP29, EPB41L5, ITGB3BP, TBC1D25, and FBXW7, which one exhibits the highest cell-type specificity in pancreatic beta cells with potential relevance to type 1 diabetes mellitus? Within the PINNACLE dataset, identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings. Next, intersect these targets with the type b pancreatic cell-activated genes from PINNACLE to generate a refined list of cell-type–specific targets. Compute the average embedding of these genes as a reference and then calculate the cosine similarity between this reference and each individual gene. If one gene exhibits a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SH3PXD2A', 'PABPC1L2B', 'MIEN1', 'BHLHE40', 'LINC01396']",type 1 diabetes mellitus,type b pancreatic cell,MIEN1,"Which gene among SH3PXD2A, PABPC1L2B, MIEN1, BHLHE40, and LINC01396 exhibits the highest specificity for type B pancreatic cells, thereby representing the most promising target for interventions in type 1 diabetes mellitus?","Which gene among SH3PXD2A, PABPC1L2B, MIEN1, BHLHE40, and LINC01396 exhibits the highest specificity for type B pancreatic cells, thereby representing the most promising target for interventions in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Then, among the type b pancreatic cell-activated genes in PINNACLE, determine which ones overlap with these targets to define the cell-type–specific targets for type 1 diabetes. Next, compute the average embedding for this set and calculate the cosine similarity between this reference embedding and each individual target. If one gene exhibits a significantly higher similarity score than the others, designate it as the top candidate and provide a concise, evidence-supported rationale for its biological relevance."
"['CABP7', 'HMX1', 'NDRG3', 'LINC02101', 'SMTNL1']",type 1 diabetes mellitus,type b pancreatic cell,CABP7,"Which gene among CABP7, HMX1, NDRG3, LINC02101, and SMTNL1 exhibits the highest cell-type specificity in type B pancreatic cells, making it the most promising candidate for targeting in type 1 diabetes mellitus?","Which gene among CABP7, HMX1, NDRG3, LINC02101, and SMTNL1 exhibits the highest cell-type specificity in type B pancreatic cells, making it the most promising candidate for targeting in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type-specific embeddings from PINNACLE. Then, among genes activated in type B pancreatic cells, determine which overlap with these targets. Compute the average embedding of these overlapping targets as a reference and calculate the cosine similarity between this reference and each target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['C6orf136', 'MEG3', 'PLEKHG4B', 'DCTN2', 'ZDHHC12']",type 1 diabetes mellitus,type b pancreatic cell,C6orf136,"Among the genes C6orf136, MEG3, PLEKHG4B, DCTN2, and ZDHHC12, which one exhibits the greatest cell-type specificity in pancreatic beta cells for targeting type 1 diabetes mellitus?","Among the genes C6orf136, MEG3, PLEKHG4B, DCTN2, and ZDHHC12, which one exhibits the greatest cell-type specificity in pancreatic beta cells for targeting type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus (T1DM) and obtain their cell type-specific embeddings from the PINNACLE dataset. Next, determine which type b pancreatic cell-activated genes in PINNACLE overlap with these targets; this overlapping set represents the cell type–specific T1DM targets. Compute the average embedding for these overlapping genes as a reference, then calculate the cosine similarity between this reference and each individual gene embedding. If one gene demonstrates markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FGF10', 'TTC29', 'SEL1L2', 'CCDC42', 'IGFBP7']",type 1 diabetes mellitus,type b pancreatic cell,IGFBP7,"Among the genes FGF10, TTC29, SEL1L2, CCDC42, and IGFBP7, which one exhibits the highest cell-type specificity in type B pancreatic cells for potential targeting in type 1 diabetes mellitus?","Among the genes FGF10, TTC29, SEL1L2, CCDC42, and IGFBP7, which one exhibits the highest cell-type specificity in type B pancreatic cells for potential targeting in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the genes activated in type b pancreatic cells within the dataset. For this intersecting set, calculate the average embedding as a reference and use cosine similarity to compare each target’s embedding to this reference vector. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['KCNAB3', 'SEPTIN8', 'SLC7A10', 'BCL9L', 'ZMAT5']",type 1 diabetes mellitus,type b pancreatic cell,ZMAT5,"Among KCNAB3, SEPTIN8, SLC7A10, BCL9L, and ZMAT5, which gene exhibits the highest specificity for pancreatic beta cells, making it the most promising candidate target for type 1 diabetes mellitus?","Among KCNAB3, SEPTIN8, SLC7A10, BCL9L, and ZMAT5, which gene exhibits the highest specificity for pancreatic beta cells, making it the most promising candidate target for type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the type B pancreatic cell-activated genes in PINNACLE to define the cell-type–specific targets for the disease. Compute the average embedding of this overlapping set, then calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TYMS', 'TJP2', 'ARHGEF10L', 'PFKL', 'ITGAD']",type 1 diabetes mellitus,type b pancreatic cell,PFKL,"Which gene among TYMS, TJP2, ARHGEF10L, PFKL, and ITGAD exhibits the highest cell-type specificity in pancreatic beta cells for use as a target in type 1 diabetes mellitus therapy?","Which gene among TYMS, TJP2, ARHGEF10L, PFKL, and ITGAD exhibits the highest cell-type specificity in pancreatic beta cells for use as a target in type 1 diabetes mellitus therapy? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which genes activated in type b pancreatic cells within PINNACLE overlap with these targets; this overlapping set defines the cell-type–specific targets. Calculate the average embedding for these targets as a reference, then compute the cosine similarity between this reference and each individual target embedding. Identify the gene with the highest similarity as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['LINC02485', 'MORC1', 'GNAL', 'TENT4B', 'TAB1']",type 1 diabetes mellitus,type b pancreatic cell,TENT4B,"Among the genes LINC02485, MORC1, GNAL, TENT4B, and TAB1, which exhibits the highest cell-type-specific expression in type B pancreatic cells in the context of type 1 diabetes mellitus?","Among the genes LINC02485, MORC1, GNAL, TENT4B, and TAB1, which exhibits the highest cell-type-specific expression in type B pancreatic cells in the context of type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus along with their cell-type–specific embeddings from PINNACLE. Determine which of these targets overlap with the type B pancreatic cell-activated genes in PINNACLE. For the overlapping set, compute the average embedding as a reference and then calculate the cosine similarity between this reference and each individual gene’s embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['SRFBP1', 'FARP2', 'PFKFB4', 'PLA2G2F', 'TPRG1-AS1']",type 1 diabetes mellitus,type b pancreatic cell,FARP2,"Which gene among SRFBP1, FARP2, PFKFB4, PLA2G2F, and TPRG1-AS1 exhibits the highest specificity for pancreatic β cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among SRFBP1, FARP2, PFKFB4, PLA2G2F, and TPRG1-AS1 exhibits the highest specificity for pancreatic β cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the set of b-pancreatic cell–activated genes in PINNACLE, thereby defining the cell-type–specific targets. Compute the average embedding for this subset as a reference, and then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale supporting its biological relevance."
"['MANEAL', 'EIF5', 'ODF3L1', 'PRDM10', 'CDR2L']",type 1 diabetes mellitus,type b pancreatic cell,MANEAL,"Among the genes MANEAL, EIF5, ODF3L1, PRDM10, and CDR2L, which one exhibits the highest cell-type specificity in pancreatic beta cells relevant to type 1 diabetes mellitus?","Among the genes MANEAL, EIF5, ODF3L1, PRDM10, and CDR2L, which one exhibits the highest cell-type specificity in pancreatic beta cells relevant to type 1 diabetes mellitus? For type 1 diabetes mellitus, identify validated therapeutic targets and extract their cell-type–specific embeddings from PINNACLE. Then, determine which of these targets overlap with the type b pancreatic cell-activated genes in PINNACLE to establish the set of cell-type–specific targets. Compute the average embedding for this set, and calculate the cosine similarity between this average and each individual target’s embedding. If one gene demonstrates a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['RPL22L1', 'TMEM51-AS1', 'AGER', 'LINC01882', 'MTCH1']",type 1 diabetes mellitus,type b pancreatic cell,MTCH1,"Among the genes RPL22L1, TMEM51-AS1, AGER, LINC01882, and MTCH1, which exhibits the highest cell-type specificity in pancreatic beta cells for potential targeting in type 1 diabetes mellitus?","Among the genes RPL22L1, TMEM51-AS1, AGER, LINC01882, and MTCH1, which exhibits the highest cell-type specificity in pancreatic beta cells for potential targeting in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type-specific embeddings from the PINNACLE database. Next, identify the overlap between these targets and the genes activated in type b pancreatic cells in PINNACLE to define the cell-type-specific targets. Compute the average embedding of these overlapping genes as a reference and calculate the cosine similarity between this reference and each individual target’s embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['DBNDD2', 'MID1IP1', 'KLF3', 'DSG2', 'TOMM40L']",type 1 diabetes mellitus,type b pancreatic cell,KLF3,"Among DBNDD2, MID1IP1, KLF3, DSG2, and TOMM40L, which gene exhibits the highest specificity for pancreatic beta cells and thus represents the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Among DBNDD2, MID1IP1, KLF3, DSG2, and TOMM40L, which gene exhibits the highest specificity for pancreatic beta cells and thus represents the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus using the PINNACLE database, then determine the subset that overlaps with the active genes in type B pancreatic cells. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and the individual gene embeddings. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['KIF24', 'CEP295NL', 'SS18L2', 'FLVCR1', 'MYO1H']",type 1 diabetes mellitus,type b pancreatic cell,FLVCR1,"Which gene among KIF24, CEP295NL, SS18L2, FLVCR1, and MYO1H exhibits the highest cell-type specificity in pancreatic type B cells relevant to type 1 diabetes mellitus?","Which gene among KIF24, CEP295NL, SS18L2, FLVCR1, and MYO1H exhibits the highest cell-type specificity in pancreatic type B cells relevant to type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell‐type–specific embeddings from PINNACLE. Next, determine which of the pancreatic type b cell–activated genes from PINNACLE overlap with these targets to define the cell‐specific targets for type 1 diabetes. Calculate the average embedding for these overlapping targets and compute the cosine similarity between this average and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence‐based rationale for its biological relevance."
"['STARD8', 'RSPH3', 'DRG1', 'NHEG1', 'TNPO1']",type 1 diabetes mellitus,type b pancreatic cell,RSPH3,"Among the genes STARD8, RSPH3, DRG1, NHEG1, and TNPO1, which one exhibits the highest cell-type specificity in pancreatic beta cells for potential targeting of type 1 diabetes mellitus?","Among the genes STARD8, RSPH3, DRG1, NHEG1, and TNPO1, which one exhibits the highest cell-type specificity in pancreatic beta cells for potential targeting of type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type-specific embeddings from PINNACLE. Next, determine which of the type B pancreatic cell-activated genes in PINNACLE overlap with these targets. For the overlapping set, compute the average embedding and then calculate the cosine similarity between this reference and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in type 1 diabetes mellitus."
"['GLIS3', 'RHOD', 'CCDC137', 'RNF32', 'ZNF408']",type 1 diabetes mellitus,type b pancreatic cell,GLIS3,"Among GLIS3, RHOD, CCDC137, RNF32, and ZNF408, which gene exhibits the highest specificity of expression in pancreatic β-cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Among GLIS3, RHOD, CCDC137, RNF32, and ZNF408, which gene exhibits the highest specificity of expression in pancreatic β-cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes and extract their cell-type-specific embeddings from PINNACLE. Next, determine which genes from the set of batch-activated pancreatic type b cells in PINNACLE overlap with these targets, thereby defining the cell-type-specific targets for type 1 diabetes. Calculate the average embedding for this overlapping set and compute the cosine similarity between this reference embedding and each individual target. Finally, if one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FAM50A', 'CDK19', 'TAS2R50', 'TAS2R10', 'ASCL2']",type 1 diabetes mellitus,type b pancreatic cell,ASCL2,"Among the genes FAM50A, CDK19, TAS2R50, TAS2R10, and ASCL2, which one exhibits the highest specificity for pancreatic β cells, making it the most promising target for type 1 diabetes mellitus interventions?","Among the genes FAM50A, CDK19, TAS2R50, TAS2R10, and ASCL2, which one exhibits the highest specificity for pancreatic β cells, making it the most promising target for type 1 diabetes mellitus interventions? Identify validated therapeutic targets for type 1 diabetes mellitus (T1DM) and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which genes activated in type b pancreatic cells overlap with these targets to generate a set of cell-type–specific T1DM targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based explanation of its biological relevance."
"['OGFRL1', 'ZNF618', 'RSPH10B2', 'LEMD2', 'TRIM50']",type 1 diabetes mellitus,type b pancreatic cell,LEMD2,"Which gene among OGFRL1, ZNF618, RSPH10B2, LEMD2, and TRIM50 exhibits the highest cell-type specificity in type b pancreatic cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among OGFRL1, ZNF618, RSPH10B2, LEMD2, and TRIM50 exhibits the highest cell-type specificity in type b pancreatic cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from the PINNACLE database. Then, determine which type b pancreatic cell-activated genes overlap with these targets and compute the average embedding of this overlapping set as a reference. Next, calculate the cosine similarity between this reference and each individual overlapping gene’s embedding. If one gene shows a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
